PIH13 THE COST-EFFECTIVENESS OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING IN THE UNITED STATES (Englisch)
- Neue Suche nach: Ganz, M.
- Neue Suche nach: Shah, D.
- Neue Suche nach: Gidwani, R.
- Neue Suche nach: Filonenko, A.
- Neue Suche nach: Su, W.
- Neue Suche nach: Pocoski, J.
- Neue Suche nach: Law, A.
- Neue Suche nach: Ganz, M.
- Neue Suche nach: Shah, D.
- Neue Suche nach: Gidwani, R.
- Neue Suche nach: Filonenko, A.
- Neue Suche nach: Su, W.
- Neue Suche nach: Pocoski, J.
- Neue Suche nach: Law, A.
In:
VALUE IN HEALTH
;
14
, 3
;
A107
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PIH13 THE COST-EFFECTIVENESS OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING IN THE UNITED STATES
-
Beteiligte:Ganz, M. ( Autor:in ) / Shah, D. ( Autor:in ) / Gidwani, R. ( Autor:in ) / Filonenko, A. ( Autor:in ) / Su, W. ( Autor:in ) / Pocoski, J. ( Autor:in ) / Law, A. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 14, 3 ; A107
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:A107
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 14, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A1
-
CO1 COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTINGBonafede, R. P. / Pearson, D. / Babich, J. / Chastek, B. / Becker, L. / Watson, C. / Chaudhari, S. / Harrison, D. J. / Gandra, S. R. et al. | 2011
- A4
-
SB3 INNOVATIVE DESIGN FOR A COMPARATIVE EFFECTIVENESS STUDY OF SCHIZOPHRENIA TREATMENTS: ANALYSIS OF RECORD REVIEW DATA INCORPORATING RANDOMIZATION AND PROPENSITY SCORE MATCHINGMcCarrier, K. P. / Durkin, M. B. / Dirani, R. / Markowitz, M. / Slabaugh, S. L. / Martin, M. L. et al. | 2011
- A5
-
CE4 USING DYNAMIC TRANSMISSION MODELS TO ESTIMATE THE COST EFFECTIVENESS OF VACCINES: FOUR DIFFERENT METHODS AND THEIR RELEVANCE FOR DECISION MAKERSMauskopf, J. / Talbird, S. E. / Standaert, B. et al. | 2011
- A8
-
MC3 IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE II DIABETES AND COMORBID HYPERTENSION CONTROLLING FOR ENDOGENEITY BIASAn, J. J. / Nichol, M. B. et al. | 2011
- A9
-
EE4 BOOTSTRAPPING USED TO PROVIDE ROBUST MEAN AND VARIANCE ESTIMATES FOR COMPARING PATIENTS TREATED WITH LIRAGLUTIDE TO A LARGE COMPARISON COHORTMcAdam Marx, C. / Ye, X. / Bouchard, J. / Aagren, M. / Conner, C. / Brixner, D. et al. | 2011
- A10
-
MD1 USING COST-EFFECTIVENESS INFORMATION TO ALLOCATE MEDICARE RESOURCES – HOW MUCH MORE HEALTH FOR THE MONEY?Chambers, J. D. / Cohen, J. T. / Neumann, P. J. / Lord, J. / Buxton, M. et al. | 2011
- A12
-
PHP4 WHEN STAKEHOLDERS DON'T AGREE: DISCREPANCIES IN MAB “APPROVALS” OVER THE PAST TEN YEARSMiller, K. L. / Stevens, C. A. et al. | 2011
- A13
-
PHP10 THE TEMPORAL ASSOCIATION BETWEEN PRESCRIBED OPIOIDS AND THE NATIONAL DEATH RATE DUE TO OPIOID POISONINGGokhale, M. N. / Martin, B. et al. | 2011
- A14
-
PHP16 ANALYZING THE EUROPEAN EXTERNAL REFERENCE PRICING SYSTEM USING SPECTRAL GRAPH THEORYLindgren, P. / kerborg, x. et al. | 2011
- A15
-
PHP23 THE IMPACT OF MEDICARE PART D ON PRESCRIPTION VOLUME AND OUT-OF-POCKET COSTS OF MEDICALLY NECESSARY DRUGSSepulveda, B. / Doyle, J. / White, C. et al. | 2011
- A16
-
PHP28 COMPLIANCE WITH TREATMENT GUIDELINE RECOMMENDATIONS: USE OF OVER-THE-COUNTER MEDICATIONS IN PATIENTS RECEIVING BISPHOSPHONATES, ANTIEPILEPTICS, OR CHRONIC OPIOIDSBarnes, K. D. / Heaton, P. C. et al. | 2011
- A17
-
PHP35 DECISION MAKING IN BRAZIL BASED ON HEALTH TECHNOLOGY ASSESSMENT: THE GOOD, THE BAD, AND THE FUTUREMachado, M. / Fonseca, E. / Fonseca, M. et al. | 2011
- A18
-
PHP41 THE CHANGING LANDSCAPE OF ORPHAN DRUG PROVISION IN THE EU5 AND THE UNITED STATESMcConkey, D. et al. | 2011
- A20
-
PHP52 INCREASE IN UNINTENTIONAL FATAL POISONINGS BY NOXIOUS SUBSTANCES IN KANSAS CITY, MISSOURI, FROM 1999 TO 2008Liu, Y. / Cai, J. / Hong, L. / Hoff, G. L. / Okah, F. A. et al. | 2011
- A21
-
PHP59 THE AVAILABILITY AND SIGNIFICANCE OF COST-EFFECTIVENESS DATA FOR INFORMING DECISIONS TO ADD NEW DRUGS TO THE NATIONAL LIST OF HEALTH SERVICES IN ISRAELGreenberg, D. / Wacht, O. / Siebzehner, M. I. et al. | 2011
- A22
-
PHP64 THE RELATIONSHIP BETWEEN FINANCIAL IMPACT AND THE LIKELIHOOD OF DRUG REIMBURSEMENT IN THE AUSTRALIAN HEALTH CARE SYSTEMMauskopf, J. / Chirila, C. / Masaquel, C. / Boye, K. S. / Bowman, L. / Birt, J. / Grainger, D. et al. | 2011
- A23
-
PHP69 HOW MUCH FOR A QALY IN KOREAKim, Y. / Shin, S. / Park, S. / Song, H. / Park, J. / Bae, E. / Ahn, J. et al. | 2011
- A24
-
PHP74 CLINICAL TRIAL LEARNING CURVES AFFECT OUTCOMES MEASUREMENT, PATIENT SAFETY AND TRIAL SUCCESS: CONTRIBUTING FACTORS AND A POTENTIAL SOLUTION IN CLINICAL TRIAL SIMULATIONSpinner, D. S. / Walter, J. W. / Vazquez-Gragg, M. / Bloise, T. / Stafford-Smith, M. / Faulkner, E. C. / Taekman, J. M. et al. | 2011
- A25
-
PHP80 RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION AMONG FUTURE PHARMACISTSSura, S. D. / Chabria, A. / Sansgiry, S. et al. | 2011
- A26
-
PHP85 APPLYING FUZZY MULTIPLE CRITERIA DECISION MAKING TO ESTABLISH A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM WITH COVERAGE IMPLICATIONS IN TAIWAN NATIONAL HEALTH INSURANCELin, C. W. et al. | 2011
- A27
-
PHP90 TRENDS IN UTILIZATION OF PREGNANCY RISK CATEGORY D AND X DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATESShah, A. J. / Patil, D. S. / Kadakia, A. / Aparasu, R. R. et al. | 2011
- A28
-
PHP95 EXPECTED CHANGES IN HEALTH CARE UTILIZATION DUE TO PATIENT PROTECTION AND AFFORDABLE CARE ACTGhushchyan, V. H. / Sullivan, P. W. / Naim, A. / Nair, K. V. et al. | 2011
- A30
-
PHP106 DISPARITY IN ACCESS TO NOVEL DIABETIC AGENTS FOR MEDICARE PART D ELDERLY COMPARED TO COMMERCIAL INSURED PATIENTS: INSIGHT INTO DOWNSTREAM EFFECTS OF CMS FORMULARY COVERAGE GUIDELINES FOR PDP'SSchwartz, E. L. / Davis, E. A. / Belazi, D. / Hasan, S. et al. | 2011
- A31
-
PHP112 DEFINITIONAL CRITERIA FOR CHRONIC FATIGUE SYNDROME: A CRITICAL REVIEWChristley, Y. / Duffy, T. / Martin, C. R. et al. | 2011
- A32
-
PCV3 RISK OF HOSPITALIZATIONS FOR VENOUS THROMBOEMBOLISM IN ATYPICAL VERSUS TYPICAL ANTIPSYCHOTIC USERS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIES: A CLAIMS DATA ANALYSISDharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. et al. | 2011
- A34
-
PCV15 PREDICTORS OF THE COMBINED DIAGNOSIS HYPERLIPIDEMIA AND HYPERTENSION - A NHANES 2007-2008 STUDYBhounsule, P. / Abughosh, S. et al. | 2011
- A35
-
PCV20 PERSISTENCE WITH STATINS AND PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS: A POPULATION-BASED COHORT STUDYChodick, G. / Shalev, V. / Goldstein, I. / Porath, A. / Simah, V. et al. | 2011
- A37
-
PCV31 ASSOCIATION BETWEEN HEART FAILURE AND IN-HOSPITAL MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTIONPhatak, H. / Pan, X. / Kawabata, H. et al. | 2011
- A38
-
PCV36 EVALUATION OF THE HOSPITAL RESOURCE UTILIZATION ASSOCIATED WITH TOLVAPTAN USAGE AMONG HEART FAILURE PATIENTS WITH HYPONATREMIA FROM THE EVEREST TRIALDasta, J. F. / Chiong, J. R. / Kim, S. / Lin, J. et al. | 2011
- A39
-
PCV42 A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTIONRao, S. / Lin, F. J. / Ojo, O. / Patel, V. / Yu, S. / Zhan, L. / Touchette, D. R. et al. | 2011
- A40
-
PCV47 COST-EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN IN PATIENTS WITH NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN BRAZILPepe, C. / Machado, M. / Olimpio, A. / Canella, M. / Ramos, R. et al. | 2011
- A42
-
PCV58 ASSOCIATION BETWEEN HEART FAILURE AND RESOURCE UTILIZATION IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTIONPan, X. / Kawabata, H. / Phatak, H. et al. | 2011
- A43
-
PCV63 THE IMPACT OF CARDIOVASCULAR DISEASE HOSPITALIZATIONS ON CHANGES IN PATIENT ADHERENCE TO ANTIHYPERTENISVE DRUGS IN A MEDICAID POPULATIONYan, X. / Shaya, F. T. et al. | 2011
- A44
-
PCV68 FACTORS ASSOCIATED WITH NON-ADMINISTRATION OF ORDERED PHARMACOLOGIC VENOUS THROMBOEMBOLISM PROPHYLAXIS DOSESShermock, K. M. / Shafir, V. / Streiff, M. B. / Lavallee, D. M. / Pinto, B. L. / Haut, E. / Kraus, P. / Efird, L. / Elder, S. / Rand, C. et al. | 2011
- A45
-
PCV74 ASSESSMENT OF KNOWLEDGE ABOUT HYPERTENSION (HTN) AMONG HYPERTENSIVE PATIENTS IN SOUTHERN PUNJAB, PAKISTANAtif, M. / Asif, M. / Saleem, F. / Ahmad, N. / Saqib, N. et al. | 2011
- A46
-
PCV79 IMPACT OF DISEASE MANAGEMENT PROGRAM “DE TODO CORAZON” OF MUTUAL SER HMO TO CONTROL CARDIOVASCULAR RISK, COHORT 2004-2009, COLOMBIAPaz, J. J. / Granados, C. E. / Morales, C. / Rodriguez, N. / Buitrago, L. A. / Guete, A. / Caceres, H. A. / Ramirez, P. / Pardo, R. et al. | 2011
- A47
-
PCV84 EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CAREMartinez Valverde, S. / Reyes Morales, H. / Castro Rios, A. / Perez Cuevas, R. / Klunder Klunder, M. / Salinas Escudero, G. et al. | 2011
- A48
-
PCV90 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG PATIENTS IN A LARGE EMPLOYER-BASED CLAIMS DATABASEZhao, Z. / Peng, X. / Bae, J. P. / Sponseller, C. A. / LeNarz, L. A. et al. | 2011
- A49
-
PCV95 USING COMPUTERIZED PHYSICIAN ORDER ENTRY OF ANTI-HYPERTENSIVE MEDICATIONS TO CONNECT INDICATIONS WITH PRESCRIBING AND IMPROVE PROBLEM LIST DOCUMENTATIONGalanter, W. / Walton, S. / Falck, S. / Rosencranz, H. / Adimadhyam, S. et al. | 2011
- A50
-
PCV100 HEALTH CARE UTILIZATION AND COSTS FOR A MEDICATION THERAPY MANAGEMENT (MTM) PROGRAMPinto, S. L. / Partha, G. et al. | 2011
- A52
-
PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUESGandhi, P. K. / Ried, L. D. / Huang, I. C. / Kimberlin, C. / Kauf, T. / Suh, D. C. et al. | 2011
- A53
-
PSS4 SYSTEMATIC REVIEW OF THE EPIDEMIOLOGIC LITERATURE ON ATOPIC DERMATITIS IN CHILDRENBerbari, J. / Reynolds, S. / Heil-Ruess, M. / Iskedjian, M. et al. | 2011
- A56
-
PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASISMamolo, C. / Bushmakin, A. G. / Cappelleri, J. C. / Stewart, M. et al. | 2011
- A57
-
PSS25 MEDICATION ADHERENCE TO TOPICAL MEDICATIONS AND HEALTHCARE EXPENDITURES IN MEDICAID-ENROLLED CHILD WITH ATOPIC DERMATITISOu, H. T. / Feldman, S. R. / Balkrishnan, R. et al. | 2011
- A58
-
PSS30 BURDEN OF INFANTILE HEMANGIOMA: DEVELOPMENT OF A QUESTIONNAIRETaieb, C. / Voisard, J. J. / Ruiz, F. et al. | 2011
- A59
-
PSY6 TRANSFUSIONAL IRON OVERLOAD (TIO) MONITORING AND TREATMENT: FINDINGS FROM AN ELECTRONIC MEDICAL RECORDS REVIEW STUDY AT THE MOFFITT CANCER CENTER AND RESEARCH INSTITUTEDuh, M. S. / Wetzstein, G. / Guo, A. / Sasane, M. / Sarda, S. P. / Korves, C. / Wang, S. T. / Wei, R. / Clinton, B. / Ray, L. et al. | 2011
- A60
-
PSY11 BURDEN OF ILLNESS IN FIBROMYALGIA SYNDROME: THE PATIENTS' PERSPECTIVESLee, S. S. / Kim, S. H. / Kim, S. K. / Lee, C. K. / Lee, H. S. / Lee, S. H. / Park, Y. B. / Ko, S. K. / Park, H. J. et al. | 2011
- A61
-
PSY16 PROJECTING THE LIFETIME ECONOMIC COSTS OF OBESITY: A BMI TRAJECTORY-BASED MODELWang, B. C. / Garrison, L. / Alfonso-Cristancho, R. / Wong, E. / Flum, D. / Arterburn, D. / Sullivan, S. D. et al. | 2011
- A62
-
PSY21 COST-EFFECTIVENESS ANALISYS OF TREATMENT WITH AMFEPRAMONE (DIETHYLPROPION) IN OBESITY IN MEXICORamirez Ramirez, M. / Soto-Molina, H. / Rizzoli-Cordoba, A. / Delgado-Ginebra, I. / Pizarro-Castellanos, M. et al. | 2011
- A63
-
PSY26 IMPACT OF HYPONATREMIA ON PATIENT OUTCOMES AND HEALTH CARE RESOURCE UTILIZATION IN HOSPITALIZED PATIENTSDeitelzweig, S. / Amin, A. / Lin, J. / Belk, K. / Baumer, D. / Lowe, T. et al. | 2011
- A64
-
PSY31 HEMOPHILIA A: PATIENT IMPACT AND ECONOMIC BURDEN OF THE DISEASEStrandberg-Larsen, M. / Gater, A. / Thomson, A. et al. | 2011
- A65
-
PSY36 DEVELOPMENT OF THE LUPUS IMPACT TRACKER: A TOOL FOR PATIENTS AND PHYSICIANS TO ASSESS AND MONITOR THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)Jolly, M. / Kosinski, M. / Garris, C. P. / Jhingran, P. M. / Mikolaitis, R. A. / Dennis, G. / Wallace, D. J. / Clarke, A. / Parke, A. / Dooley, M. A. et al. | 2011
- A66
-
PSY42 EPIDEMIOLOGY AND QALITY OF LIFE OF ANEMIC PATIENTS ON DIALYSIS IN RUSSIA: PATIENT-REPORTED DATAVorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. / Eliseeva, E. / Baev, V. / Vezikova, N. et al. | 2011
- A67
-
PSY47 WILLINGNESS TO PAY (WTP) FOR WEIGHT LOSS COACHING: RESULTS FROM THE POWER TRIALAlavi, R. / Appel, L. / Brancati, F. / Clark, J. / Mohr, P. / Daumit, G. et al. | 2011
- A69
-
PSY59 IMPACT OF OBESITY ON AGE-SPECIFIC PREVALENCE OF CHRONIC DISEASES IN THE UNITED STATESPatel, J. G. / Shah, A. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. L. et al. | 2011
- A70
-
PSY64 GE CENTRICITY® ELECTRONIC MEDICAL RECORDS STUDY: COMORBIDITIES AND BIOLOGIC EXPERIENCE AMONG PATIENTS RECEIVING GOLIMUMABTandon, N. / Carter, C. / Haas, S. / Gunnarsson, C. et al. | 2011
- A71
-
PSY70 ASSOCIATION OF PROVIDER CONTINUITY WITH HOSPITALIZATION AMONG FLORIDA MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD)Ma, Q. / Kauf, T. / Hall, A. G. et al. | 2011
- A72
-
PSY75 PREVALENCE RATIOS AGAINST ODDS RATIOS AS EFFECT MEASURES IN A CROSS-SECTIONAL STUDY OF OBESITY AND ITS CHRONIC COMORBID CONDITIONSPatel, J. G. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. et al. | 2011
- A73
-
PSY80 PRIORITIZATION AND WEIGHTING OF PATIENT-RELEVANT ENDPOINTS (PRES) AS PART OF THE IQWIGS EFFICIENCY FRONTIER METHOD IN GERMANYMü / hlbacher, A. / Bridges, J. F. / Bethge, S. / Dintsios, C. M. / Schwalm, A. / Nü / bling, M. et al. | 2011
- A74
-
PUK4 CUMULATIVE EXPOSURE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND THE PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD)Yarger, S. / Nwokeji, E. / Trice, S. / Chao, S. / Devine, J. / Potyk, R. / Gutke, G. / Bonnema, A. et al. | 2011
- A76
-
PUK14 A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CAREGanz, M. / Clemens, J. Q. / Anger, J. / Denevich, S. / Shah, D. / Carlson, A. / Wittek, M. R. / Pashos, C. et al. | 2011
- A77
-
PUK19 KIT73: PRELIMINARY REPORTS OF IMMUNOSUPRESSANT THERAPY PATTERNS IN A COHORT OF POST KIDNEY TRANSPLANT PATIENTS IN BRAZILCarvalho, D. D. / Garcia, V. / Abbud-Filho, M. / Nishikawa, A. M. / Asano, E. / Nita, M. E. / Szabo, S. M. / Levy, A. R. / Carvalho, J. F. / Donato, B. M. et al. | 2011
- A78
-
PUK24 USE OF BIOMARKERS IN PROPENSITY SCORE MATCHING TO MITIGATE CHANNELING BIAS IN A RETROSPECTIVE COHORT OF ESRD PATIENTSWilson, S. M. / Rubin, J. L. et al. | 2011
- A79
-
PMD5 OUTCOME STUDY OF DRUG ELUTING STENT (DES) VERSUS BARE METAL STENT (BMS) IN HONG KONG: A 6-MONTH PILOT STUDYLee, V. / Yan, B. / Chan, T. / Woo, A. / Lee, K. K. / Yu, C. M. et al. | 2011
- A80
-
PMD11 IDENTIFYING POTENTIAL DRIVERS OF COST SAVINGS WITH INSULIN ADMINISTRATION DEVICES IN TYPE-2 DIABETES IN THE UNITED STATESPollock, R. F. / Curtis, B. / Boye, K. S. / Timlin, L. / Valentine, W. J. et al. | 2011
- A81
-
PMD16 COMPARISON OF COST AND CLINICAL OUTCOMES OF OPEN VERSUS LAPAROSCOPIC THORACIC PROCEDURES IN THE UNITED STATESHashemi, L. / Minshall, M. E. et al. | 2011
- A82
-
PMD21 IS CYBERKNIFE A COST-EFFECTIVE OPTION FOR TREATING PROSTATE CANCER?Parthan, A. / Pruttivarasin, N. / Taylor, D. / Davies, D. / Yang, G. / Pawar, V. / Weinstein, M. et al. | 2011
- A85
-
PMD40 METHODOLOGICAL CONSIDERATIONS IN MODELING THE ECONOMIC VALUE OF DIAGNOSTIC ACCURACYFoley, K. / Lim, S. / Schulman, K. L. et al. | 2011
- A86
-
PSU4 SURGEON'S VOLUME-OUTCOMES RELATIONSHIP FOR LOBECTOMIES AND WEDGE RESECTIONS FOR CANCER USING VIDEO-ASSISTED THORACOSCOPIC TECHNIQUESDavid, G. / Gunnarsson, C. / Moore, M. / Howington, J. / Miller, D. / Maddaus, M. / McKenna, R. / Meyers, B. / Swanson, S. et al. | 2011
- A87
-
PSU9 ECONOMIC EVALUATION OF THE CURRENT TREND TOWARDS MORE UNCEMENTED FIXATION IN PRIMARY HIP ARTHROPLASTIES AND THE POTENTIAL IMPACT OF CHANGES OF THE DEVELOPMENT IN ENGLAND AND WALESKontekakis, A. / Gaiser, S. et al. | 2011
- A88
-
PSU14 HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS ON KIDNEY TRANSPLANT WAITING LIST - WHAT FACTORS REALLY MATTER?Ong, S. C. / Chow, W. L. / van der Erf, S. / Joshi, V. D. / Tee, P. S. / Lu, Y. M. / Kee, T. Y. et al. | 2011
- A89
-
PSU20 IS THERE INDICATION BIAS OF RETROSPECTIVE OBSERVATIONAL STUDY?Choi, J. E. / Jang, E. J. / Jung, S. Y. / Lee, E. J. / Lee, N. R. / Joo, C. K. et al. | 2011
- A91
-
PDB6 LONG-TERM EFFECTIVENESS OF MANAGING DIABETES WITH THE CHRONIC CARE MODEL: SIMULATIONS PERFORMED USING ARCHESZgibor, J. C. / Kuo, S. / Schuetz, C. A. / Roberts, M. S. / Cohen, M. D. et al. | 2011
- A92
-
PDB11 COMPARISON OF MULTIVARIABLE-ADJUSTED LOGISTIC REGRESSION WITH PROPENSITY SCORE-MATCHED, PROPENSITY SCORE-STRATIFIED, AND PROPENSITY SCORE-ADJUSTED LOGISTIC REGRESSION MODELSKhoza, S. / Barner, J. C. / Richards, K. et al. | 2011
- A94
-
PDB22 INSULIN GLARGINE PLUS OHAS VERSUS BIPHASIC INSULIN IN TYPE-2 DIABETES – A COST COMPARISONTilling, C. / Owens, D. / Keech, M. et al. | 2011
- A96
-
PDB32 ECONOMIC EVALUATION OF RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN CANADAHaig, J. / Lawrence, D. / Barbeau, M. / Blouin, J. / Cruess, A. et al. | 2011
- A97
-
PDB37 MAIL-ORDER PHARMACY USE AND MEDICATION ADHERENCE AMONG MEDICARE PART D BENEFICIARIES WITH DIABETESZhang, L. / Zakharyan, A. / Stockl, K. M. / Harada, A. S. / Curtis, B. S. / Solow, B. K. et al. | 2011
- A98
-
PDB43 TREATMENT COMPLIANCE TO DIABETES CARE: A CROSS-SECTIONAL STUDY FROM PAKISTANParveen, M. / Piyarali, S. et al. | 2011
- A99
-
PDB48 DO WE KNOW WHAT ARE THEY TRADING OFF? – A FEASIBILITY STUDY TO MEASURE QUALITY OF LIFE IN TAIWANESE TYPE-2 DIABETES OUTPATIENTS BY TIME-TRADE-OFF METHODHuang, L. H. / Chen, L. C. / Huang, Y. B. / Hwang, S. J. et al. | 2011
- A100
-
PDB53 PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN T2DM PATIENTS TERTIARY CARE HOSPITAL IN INDIARaval, A. D. / Dhanaraj, E. / Bhansali, A. et al. | 2011
- A101
-
PDB58 WHAT IS THE IMPACT OF GENERIC SUBSTITUTION OF ROSIGLITAZONE ON PATIENT OUTCOMES AND TREATMENT COSTS? AN HMO EXPERIENCETriki, N. / Greenberg, D. / Mossinson, D. / Shani, S. et al. | 2011
- A102
-
PDB64 EVALUATION OF THE BURDEN OF ILLNESS OF TYPE-2 DIABETES MELLITUS IN A MEDICARE POPULATIONCostantino, M. E. / Song, F. / Stacy, J. N. / Aagren, M. / Bouchard, J. / Marrett, E. et al. | 2011
- A103
-
PDB69 EXENATIDE (BID) AND LIRAGLUTIDE (QD) TREATMENT PATTERNS AMONG TYPE-2 DIABETES PATIENTS IN GERMANYMiller, L. A. / Burudpakdee, C. / Zagar, A. / Bhosle, M. / Reaney, M. / Schabert, V. F. et al. | 2011
- A105
-
PIH4 COMPARATIVE EFFECTIVENESS OF BANKED DONOR MILK FOR PREMATURE INFANTS: EFFICIENCY OF A MILK BANK MODEL INTEGRATED IN A BLOOD BANK SETTINGRicher, E. / Dourdin, N. / Goetghebeur, M. et al. | 2011
- A106
-
PIH9 COSTS TO THE NATIONAL HEALTH INSURACE SCHEME OF THE FREE MATERNAL HEALTH SERVICE CHALLENGES AND IMPLICATIONS FOR SUSTAINABILITY IN GHANAOdame, E. et al. | 2011
- A108
-
PIH20 ECONOMIC EVALUATION OF THE USE OF EXOGENOUS PULMONARY SURFACTANTS IN PRETERM NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME IN MEXICAN POPULATION COVERED BY THE NEW GENERATION MEDICAL INSURANCESalinas Escudero, G. / Martinez Valverde, S. / Villasis Keever, M. A. / Garduñ / o Espinosa, J. / Reyes Ló / pez, A. / Muñ / oz Herná / ndez, O. et al. | 2011
- A109
-
PIH25 IMPACT OF PATIENT BEHAVIORS AND ATTITUDES ON TERIPARATIDE ADHERENCE IN A MEDICARE PART D POPULATIONFoster, S. / Hazel-Fernandez, L. A. / Uribe, C. / Song, F. / Thomas, N. / Burge, R. T. / Krohn, K. et al. | 2011
- A111
-
PIH37 DUAL VETERAN HEALTH ADMINISTRATION AND MEDICARE USE AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONSAjmera, M. R. / Wilkins, T. L. / Sambamoorthi, U. et al. | 2011
- A112
-
PIH42 A NET BENEFIT FRAMEWORK (NBF) ANALYSIS OF CHART DATA FOR HAEMOPHILIA INHIBITOR PATIENTSWeatherall, J. / Mesterton, J. / Lindgren, P. / Dalen, J. et al. | 2011
- A113
-
PIN1 VACCINE-ASSOCIATED GUILLAIN-BARRE SYNDROME: A PHARMACOVIGILANCE ANALYSIS OF DATA IN THE UNITED STATES' VACCINE ADVERSE EVENT REPORTING SYSTEM (1990-2009)Ali, A. K. et al. | 2011
- A114
-
PIN6 TRENDS OF HEPATITIS A INCIDENCE FROM 2005 TO 2008Eisenberg, D. / Changolkar, A. K. / Misurski, D. A. et al. | 2011
- A116
-
PIN17 TREATMENT PATTERNS AND DRUG TREATMENT COSTS ASSOCIATED WITH NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)-BASED ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE HIV-1 INFECTED PATIENTSDiels, J. / Langham, S. / Nuyts, G. / Adriaenssen, I. et al. | 2011
- A117
-
PIN23 COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR (ATV+RTV) COMPARED WITH LOPINAVIR/RITONAVIR (LPV+RTV) IN TREATMENT-NAÏVE HIV-INFECTED PATIENTS IN MEXICO: A MODEL BASED ON THE CASTLE STUDYJuarez-Garcia, A. / Martinez-Rivera, G. / Donato, B. M. et al. | 2011
- A118
-
PIN29 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS WITH FAILURE TO VANCOMYCIN THERAPY IN MEXICOBriones, B. / Martinez Revelles, M. / Garcí / a-Contreras, F. et al. | 2011
- A119
-
PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSISTarride, J. E. / Burke, N. / von Keyserlingk, C. / O'Reilly, D. / Xie, F. / Goeree, R. et al. | 2011
- A120
-
PIN39 IMMUNIZATION BARRIERS AND SUGGESTED SOLUTIONS IN IRAQAl-lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Basher, A. Y. et al. | 2011
- A121
-
PIN45 IMPACT OF GOVERNMENT SPONSORED POLIO CONTROL PROGRAM ON KNOWLEDGE, ATTITUDE AND PERCEPTION OF POLIO IN GENERAL COMMUNITY OF BAHAWALPUR, PAKISTANAtif, M. / Asif, M. / Sulaiman, A. / Saleem, F. / Ahmad, N. / Saqib, N. / Qamar, M. et al. | 2011
- A122
-
PIN52 MAPPING STATE AND FEDERAL IMMUNIZATION RECORDS POLICIESHedden, E. / Jessop, A. / Field, R. I. et al. | 2011
- A123
-
PMS4 THE ASSOCIATION BETWEEN TERIPARATIDE PERSISTENCE AND FRACTURE OUTCOMES IN A US CLAIMS DATABASEYu, S. / Foster, S. / Burge, R. / Anderson, J. / Gelwicks, S. / Meadows, E. et al. | 2011
- A124
-
PMS11 APPLYING THE STRATIFIED PROPENSITY SCORE MATCHING METHOD WHEN ESTIMATING HEALTH CARE COSTS OF RHEUMATOID ARTHRITIS PATIENTSBaser, O. / Xie, L. et al. | 2011
- A125
-
PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASEPark, S. J. / Lee, E. K. et al. | 2011
- A126
-
PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSISAlfonso-Cristancho, R. / Serra, N. / Aiello, E. C. / Roa, C. N. et al. | 2011
- A127
-
PMS26 COST-EFFECTIVENESS MODELING IN OSTEOPOROSIS: A SYSTEMATIC LITERATURE REVIEW AND OVERVIEWSmolen, H. J. / Myers, J. A. / Smolen, L. J. et al. | 2011
- A128
-
PMS31 TITLE: THE RELATIVE COST-EFFECTIVENESS OF THE MOST COMMON NON-SURGICAL TREATMENTS FOR NECK PAINvan der Velde, G. / Hincapié / C. / Schieir, O. / Coté / P. / Hogg-Johnson, S. / Paulden, M. / Krahn, M. et al. | 2011
- A129
-
PMS37 INDIRECT COMPARISON OF ADALIMUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIATIC ARTHRITISKirson, N. / Rao, S. / Birnbaum, H. G. / Kantor, E. / Wei, R. / Cifaldi, M. et al. | 2011
- A130
-
PMS42 CONTENT VALIDITY AND HEALTH CARE SYSTEMS: A CASE-STUDYGagol, G. / Fernandez, N. / Rouanet, S. et al. | 2011
- A131
-
PMS47 EMPLOYABILITY-ADJUSTED-LIFE-YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH GOLIMUMAB PLUS METHOTREXATE OR METHOTREXATE ALONEHan, C. / Gathany, T. / Tandon, N. / Hsia, E. et al. | 2011
- A136
-
PRS1 SEVERE ASTHMA EXACERBATIONS ASSOCIATED WITH LONG-ACTING BETA AGONISTS AMONG CHILDREN AND ADOLESCENTS WITH ASTHMAGuo, J. J. / Tsai, K. / Kelton, C. / Bian, B. / Wigle, P. et al. | 2011
- A137
-
PRS6 WATERPIPE SMOKING AMONG JORDANIAN ADULTS: PREDICTORS AND CORRELATESYang, M. / Abughosh, S. / Wu, I. H. / Sansgiry, S. / Peters, R. J. / Hawari, F. I. / Essien, E. J. et al. | 2011
- A138
-
PRS12 A NATIONAL SURVEY OF SOCIETAL COST OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SOUTH KOREAKim, J. / Park, S. / Kim, Y. / Lee, E. / Oh, Y. / Boo, Y. et al. | 2011
- A139
-
PRS17 COST EFFECTIVENESS OF TOP 20 HIGHEST SELLING DRUGSAggarwal, S. et al. | 2011
- A140
-
PRS22 COPD MAINTENANCE MEDICATION ADHERENCE: INFLUENCE ON HOSPITALIZATION AND SPENDING IN A MEDICARE POPULATIONSimoni-Wastila, L. / Wei, Y. J. / Qian, J. / Zuckerman, I. H. / Stuart, B. / Shaffer, T. / Dalal, A. / Bryant-Comstock, L. et al. | 2011
- A141
-
PRS27 THE DEVELOPMENT OF A PATIENT-REPORTED OUTCOME INSTRUMENT TO EVALUATE NIGHTTIME SYMPTOMS OF COPDPalsgrove, A. / Schaefer, M. / Hareendran, A. / Houghton, K. / Mocarski, M. / Carson, R. / Make, B. et al. | 2011
- A143
-
PRS38 EFFECT OF HAVING A PRESCRIPTION DRUG PLAN ON ASTHMA PATIENTS' USE OF CONTROLLER MEDICATIONSVaidya, V. / Peeters, M. / Partha, G. / Potnis, P. et al. | 2011
- A144
-
PRS43 REGRESSION VERSUS PROPENSITY MATCHING AS OUTCOME ANALYSIS ADJUSTMENT METHODS: EXAMPLE USING COPD INITIAL THERAPIESRoberts, M. / Dalal, A. A. et al. | 2011
- A145
-
PRM2 MEASURING DRUG THERAPY GUIDELINES ON OUTCOMES: A TUTORIALBaser, O. et al. | 2011
- A146
-
PRM8 LEGAL RESTRICTIONS ON THE USE OF QALYS IN PHARMACOECONOMIC ANALYSIS IN GERMANYGissel, C. / Goetz, G. / Repp, H. et al. | 2011
- A147
-
PRM13 COMPARISON OF DISCRETE EVENTS SIMULATION SOFTWARE FOR USE IN HEALTH ECONOMICS & OUTCOMES RESEARCHAnaya, P. et al. | 2011
- A148
-
PRM18 CAN UTILITIES EXCEED 1.0? EMPIRICAL EVIDENCE OF THE CEILING EFFECTSullivan, P. W. / Ghushchyan, V. H. et al. | 2011
- A150
-
PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSISPerampaladas, K. / Doble, B. M. / Xie, F. et al. | 2011
- A151
-
PRM35 DEVELOPMENT OF A CONCEPT LIST TO ENSURE COMPARABLE CONTENT VALIDITY BETWEEN ORIGINAL PRO QUESTIONNAIRES AND THEIR TRANSLATIONS: A REVIEW OF 15 YEARS OF LINGUISTIC VALIDATIONSMear, I. / Conway, K. et al. | 2011
- A152
-
PRM40 ISSUES CONCERNING THE TRANSLATION OF THE WORD ‘HASSLED' IN THE MORISKY MEDICATION ADHERENCE SCALE (MMAS-8)Griffin, A. / Wild, D. / Morisky, D. E. et al. | 2011
- A153
-
PRM46 R … YOU AWARE HOW USEFUL IT IS? THE VALUE OF CORRELATION COEFFICIENTS IN META-ANALYSISAl-Dakkak, I. / Patel, S. / Jen, M. H. / von Maltzahn, R. et al. | 2011
- A154
-
PCN2 SAFETY AND TREATMENT PATTERNS OF ANGIOGENESIS INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN THE UNITED KINGDOM: PRELIMINARY RESULTS OF AN ONGOING CHARTS REVIEW STUDYHawkins, R. / Wagstaff, J. / Nathan, P. / Sarda, S. P. / Vekeman, F. / Korves, C. / Dasgupta, S. / O'Mara, S. / Fitton, S. / Hayers, J. et al. | 2011
- A156
-
PCN12 RESOURCE UTILIZATION AND PERCEPTIONS OF MAJOR MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML): RESULTS OF A DELPHI PANEL STUDYBollu, V. / Quintas-Cardama, A. / Flamm, M. / Lill, M. / Thirman, M. / Ravandi-Kashani, F. / Akard, L. / Talpaz, M. et al. | 2011
- A158
-
PCN23 IMPACT OF US FOOD AND DRUG ADMINISTRATION'S BLACK BOX WARNINGS ON ADVERSE EVENTS REPORTING RATES FOR MULTIPLE MYELOMA DRUGSGarg, V. / Raisch, D. W. / Mckoy, J. / Trifilio, S. / Holbrook, J. / Samaras, A. T. / West, D. et al. | 2011
- A159
-
PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER: FRENCH HEALTH CARE PAYER PERSPECTIVELuporsi, E. / Mahi, L. / Moore, C. / Wernli, J. / Bugat, R. et al. | 2011
- A160
-
PCN34 LONG-TERM DIRECT MEDICAL COSTS IN PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA WHO RECEIVE FRONTLINE CHEMOTHERAPY WITH VERSUS WITHOUT RITUXIMAB - A SEER MEDICARE ANALYSISGriffiths, R. I. / Gleeson, M. L. / Mikhael, J. R. / Danese, M. D. et al. | 2011
- A161
-
PCN39 COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)Alemayehu, B. / Parry, D. / Engel-Nitz, N. M. / Kulakodlu, M. / Nathan, F. et al. | 2011
- A162
-
PCN46 HEALTH CARE EXPENDITURES, DISABILITY DAYS, AND RESOURCE UTILIZATION ASSOCIATED WITH CANCER IN EMPLOYER SETTINGS IN THE UNITED STATESTang, D. / Alberts, D. S. / Nevins, R. / Sullivan, S. / Skrepnek, G. H. et al. | 2011
- A164
-
PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?Djalalov, S. / Beca, J. / Hoch, J. et al. | 2011
- A166
-
PCN68 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB REISTANT PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIATaylor, M. / Lewis, L. / Lebmeier, M. / Wang, Q. et al. | 2011
- A167
-
PCN73 UTILISATION OF ANTINEOPLASTIC AGENTS IN SLOVAK REPUBLICGatialova, K. / Bellova, K. / Petrova, L. / Majtas, J. / Binder, R. et al. | 2011
- A168
-
PCN79 IMPACT OF NON-ADHERENCE TO IMATINIB ON PROGRESSION-FREE SURVIVAL AS 1ST TREATMENT FOR CHRONIC MYELOID LEUKEMIA IN BRAZIL: TWO YEARS FOLLOW UPFunke, V. A. / Moellmann-Coelho, A. / Asano, E. / Nita, M. E. / Donato, B. M. / Rahal, E. et al. | 2011
- A169
-
PCN84 PATIENTS' PREFERENCES FOR THE TREATMENT OF COLORECTAL CANCER: A DISCRETE CHOICE EXPERIMENT (DCE) SURVEYAlbassam, A. / Noyce, P. / Ashcroft, D. et al. | 2011
- A170
-
PCN89 HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE MEASURES FOR PROSTATE CANCER CLINICAL TRIALSPeeters, P. / Casamayor, M. / Moï / se, P. / Holmstrom, S. et al. | 2011
- A172
-
PCN101 HEALTH CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF METASTATIC AND RECURRENT LOCALLY-ADVANCED HEAD AND NECK CANCER PATIENTSLe, T. K. / Winfree, K. B. / Yang, H. / Marynchenko, M. / Yu, A. P. / Frois, C. / Wu, E. Q. et al. | 2011
- A173
-
PCN106 RESEARCH ON THE FACTORS AFFECTING THE ADOPTION OF HIGH VALUE MEDICAL CONSUMES IN LESS DEVELOPED AREAS OF CHINAJing, W. / Guanglian, X. et al. | 2011
- A175
-
PCN117 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH ISS STAGE AND ECOG STATUS IN MULTIPLE MYELOMAPashos, C. L. / Durie, B. G. / Mehta, J. / Toomey, K. / Terebelo, H. R. / Abonour, R. / Fonseca, R. / Gasparetto, C. / Narang, M. / Rifkin, R. M. et al. | 2011
- A176
-
PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASELepisto, E. M. / Vandergrift, J. L. / Kalemkerian, G. P. / Pisters, K. M. / Zornosa, C. / Rabin, M. S. / Reid, M. E. / Koczywas, M. / Otterson, G. A. / Ettinger, D. S. et al. | 2011
- A177
-
PCN126 OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CAREHeron, L. / De Castro Carpeñ / o, J. / Chouaid, C. / Vergnenè / gre, A. / Bischoff, H. G. / Walzer, S. et al. | 2011
- A178
-
PCN131 REPRESENTING UNCERTAINTY IN CALIBRATED CANCER TREATMENT MODELS: A PRACTICAL APPROACHTaylor, D. C. / Leahy, K. J. / Weinstein, M. et al. | 2011
- A179
-
PCN137 COMPREHENSIVE REVIEW OF MANAGEMENT EFFICIENCY STRATEGIES AMONG ONCOLOGY PRACTICES: EXISTING EVIDENCE AND OPPORTUNITIES FOR FUTURE RESEARCHGorman, K. / Miller, R. / McGarvey, N. / Corey-Lisle, P. et al. | 2011
- A180
-
PGI4 PREDICTORS OF HEPATITIS C TREATMENT INITIATIONWagner, J. S. / Goren, A. et al. | 2011
- A181
-
PGI9 COMPARISON OF DIRECT MEDICAL COSTS AND SERVICES BY POINT OF SERVICE AND PRESCRIPTION COST FOR PERSONS WITH HEPATITIS-C WITH AND WITHOUT TREATMENTBrook, R. A. / Kleinman, N. L. / Smeeding, J. et al. | 2011
- A183
-
PGI20 IBS-C PATIENT SYMPTOM REPORTS: ANALYSIS OF EXPLORATORY OPEN-ENDED QUESTIONSCarson, R. T. / Lewis, B. E. / Shiff, S. J. / Johnston, J. M. / Dennee-Sommers, B. / Lasch, K. E. / Hwang, S. / Marquis, P. et al. | 2011
- A185
-
PMH3 RISK OF HIP FRACTURES IN ELDERLY MEDICARE BENEFICIARIES USING ATYPICAL OR TYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE ANALYSISDharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. et al. | 2011
- A186
-
PMH9 RISK OF DEATH IN DUAL ELIGIBLE NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTSAparasu, R. R. / Mehta, S. / Chen, H. et al. | 2011
- A187
-
PMH14 CLINICAL EFFECTIVENESS ANALYSIS OF NALTREXONE VERSUS ACAMPROSATE AND PLACEBO IN ALCOHOL DEPENDENT PATIENTS TREATED WITH PSYCHOTHERAPYJarosz, J. / Miernik, K. / Wachal, M. / Walczak, J. et al. | 2011
- A188
-
PMH19 THE BUDGET IMPACT ANALYSIS OF NALTREXONE IN THE TREATMENT OF ALCOHOL-DEPENDENT PATIENTS IN POLANDWalczak, J. / Semeniuk, A. / Pacocha, K. / Nogas, G. et al. | 2011
- A189
-
PMH24 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL SUBSTANCE MEDICATIONS FOR ALCOHOL DEPENDENCYBaser, O. / Wang, L. / Xie, L. et al. | 2011
- A190
-
PMH29 ESTIMATION OF DIRECT COSTS OF TREATING SCHIZOPHRENIA FOR COMMUNITY-DWELLING UNITED STATES RESIDENTSDesai, P. / Lawson, K. / Barner, J. C. / Rascati, K. L. et al. | 2011
- A191
-
PMH35 COMPARISONS OF MENTAL HEALTH-RELATED MEDICAL CARE UTILIZATION AND COSTS FOLLOWING THE INITIATION OF ORAL VERSUS LONG-ACTING INJECTABLE RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIAPark, H. / Kim, D. N. / Rascati, K. L. et al. | 2011
- A192
-
PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPYSvedsater, H. / Locklear, J. / Johal, S. / Stillman, I. O. et al. | 2011
- A193
-
PMH45 MEASURES OF MEDICATION ADHERENCE IN ORAL VERSUS LONG-ACTING RISPERIDONE IN TEXAS MEDICAID PATIENTS WITH SCHIZOPHRENIAKim, D. N. / Park, H. / Rascati, K. L. et al. | 2011
- A194
-
PMH50 A TIME-TRADE-OFF STUDY OF HEALTH-RELATED QUALITY OF LIFE ADVANTAGE OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC TREATMENT FOR SCHIZOPHRENIAOsborne, R. H. / Dalton, A. / Hertel, J. / Schrover, R. / Kingsford Smith, D. et al. | 2011
- A195
-
PMH55 THE BURDEN OF DIAGNOSED DEPRESSION AND SLEEP DIFFICULTIES ON QUALITY OF LIFE, WORK PRODUCTIVITY, AND RESOURCE USEGupta, S. / Goren, A. / Gabriel, S. / Kim, E. / Dupclay, L. et al. | 2011
- A196
-
PMH60 BIPOLAR DISORDER RESULTS IN SIGNIFICANT BURDEN ON CAREGIVERS: ANALYSIS OF DATA FROM A LARGE MULTINATIONAL LONGITUDINAL STUDY (WAVE-BD)Vieta, E. / Figueira, M. L. / Bellivier, F. / Souery, D. / Blasco-Colmenares, E. / Langosch, J. M. / Medina, E. et al. | 2011
- A197
-
PMH65 EFFECT OF PRESCRIPTION MONITORING PROGRAMS (PMP'S) ON OPIOID OVERDOSE ADMISSIONPainter, J. T. et al. | 2011
- A199
-
PMH76 PHARMACIST AND PHARMACY STAFF KNOWLEDGE AND ATTITUDES TOWARDS SUICIDE AND SUICIDE PREVENTION AFTER A NATIONAL VA TRAINING PROGRAMLavigne, J. E. / King, D. A. / Lu, N. / Knox, K. L. / Kemp, J. E. et al. | 2011
- A200
-
PMH81 RELATIONSHIP BETWEEN ADHERENCE TO ANTIDEPRESSANT TREATMENTS AND DEPRESSIVE RELAPSEJung, S. Y. / Shin, S. / Song, H. / Park, J. / Ahn, J. et al. | 2011
- A201
-
PND1 PRESCRIBING PATTERNS OF DRUGS HAVING ANTICHOLINERGIC ACTIVITY IN PATIENTS WITH ALZHEIMER'S DISEASEGala, S. D. / Gupte, K. P. / Wu, W. K. et al. | 2011
- A202
-
PND6 THE IMPACT OF SPECIALTY CARE PROGRAMS ON RELAPSES OF MULTIPLE SCLEROSIS USING ADMINISTRATIVE DATATang, J. / Levin, M. C. / Bailey, J. E. / Faris, R. J. / Hong, S. H. / Chang, C. F. / Wang, J. et al. | 2011
- A203
-
PND11 THE ECONOMIC BURDEN OF OSA IN EACH OF THE METABOLIC SYNDROME COMPONENTS LEVELSGreenberg-Dotan, S. / Yan, X. / Scharf, S. M. / Shaya, F. T. et al. | 2011
- A206
-
PND27 MEDICO-ECONOMIC EVALUATION OF LACOSAMIDE ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY EPILEPSY IN THE UNITED STATESBenhaddi, H. / Helmers, S. et al. | 2011
- A207
-
PND32 HEALTH RESOURCE UTILIZATION AND COSTS FOR MIGRANEURS IN SCOTLANDBloudek, L. M. / Hansen, R. N. / Liu, L. / Batty, A. J. / Varon, S. F. / Lipton, R. B. / Sullivan, S. D. et al. | 2011
- A208
-
PND38 THE HIDDEN TOLL OF CAREGIVER BURDEN IN MULTIPLE SCLEROSISStewart, M. / Phillips, A. / Edwards, N. / Gupta, S. / Goren, A. et al. | 2011
- A209
-
PND43 THE PATIENTSLIKEME® EPILEPSY COMMUNITY: A UNIQUE INSIGHT INTO THE LIVES OF PATIENTS WITH EPILEPSYde la Loge, C. / Dimova, S. / Massagli, M. / Wicks, P. et al. | 2011
- A210
-
PND48 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN CHRONIC NEUROMUSCULAR DISORDERBanks, P. / Martin, C. R. / Petty, R. et al. | 2011
- A211
-
PND54 RETROSPECTIVE DATABASE ANALYSIS OF FREQUENCY AND COSTS OF RELAPSES AMONG MULTIPLE SCLEROSIS PATIENTSBoklage, S. / Preblick, R. / Yaldo, A. / Golick, M. / Pocoski, J. et al. | 2011
- A212
-
PND59 MEDICATION TREATMENT PATTERNS FOR MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEMTakemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Duarte, G. G. / Moretti, A. I. / Santos, P. M. / Tolentino, A. C. et al. | 2011
- A213
-
PND64 APPLICATION OF PREDICTIVE MODELING TO CLASSIFY FREQUENT SNORING IDENTIFIED FROM ROUTINE MEDICAL EXAMINATIONS USING THE NHANES DATABASERow, B. et al. | 2011
- A215
-
ISPOR 16th Annual International Meeting Financial Disclosure Information for Research Presentations| 2011
- A223
-
ISPOR 16TH Annual International Meeting Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
-
PHP97 PRO LABEL CLAIMS: AN ANALYSIS BASED ON A REVIEW OF PROS AMONG NEW MOLECULAR ENTITIES AND BIOLOGIC LICENSE APPLICATIONS 2006-2010Mordin, M. / Clark, M. / DeMuro, C. / Evans, E. / Copley-Merriman, K. / Fehnel, S. / Gnanasakthy, A. et al. | 2011
-
PHP105 HOW ARE COVERAGE DECISIONS MADE IN PUBLICLY FUNDED HEALTH CARE PROGRAMS IN LOW- AND MIDDLE-INCOME COUNTRIES?Hornberger, J. / Shewade, A. / Gutierrez, H. et al. | 2011
-
PHP111 OVER INFLATION OF THE GENETIC CONTRIBUTION TO SCHIZOPHRENIA: IMPLICATIONS FOR NOVEL THERAPEUTICSFleming, M. / Martin, C. R. et al. | 2011
-
PCV59 PERSISTENCE AND COMPLIANCE IN HYPERTENSIVE PATIENTS TREATED WITH FIXED OR UNFIXED COMBINATIONS OF ANGIOTENSIN RECEPTOR BLOCKERS, AMPLODIPINE AND HYDROCHLOROTHIAZIDESandberg, A. / Kostev, K. / Ehlken, B. / Holz, B. / Oberdiek, A. et al. | 2011
-
PSY35 VALIDATION OF THE LUPUS IMPACT TRACKERJolly, M. / Kosinski, M. / Garris, C. P. / Jhingran, P. M. / Mikolaitis, R. A. / Dennis, G. / Wallace, D. J. / Clarke, A. / Parke, A. / Dooley, M. A. et al. | 2011
-
PCV82 EVALUATION OF RELATIONSHIP BETWEEN BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS AND INTEGRATION OF SERVICES WITHIN PHYSICIAN ORGANIZATIONSSmalarz, A. / Fraser, K. / Wong, K. / Wu, N. / Wogen, J. / Boulanger, L. et al. | 2011
-
PSS6 SAFETY PROFILE OF LATANOPROST VERSUS TIMOLOL IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION: POST 2000 SETTINGGupta, J. / Siddiqui, M. K. / Jindal, R. / Sehgal, M. et al. | 2011
-
PSS9 COST-EFFECTIVENESS OF COLLAGENASE VERSUS HYDROGEL DRESSINGS FOR CHRONIC-WOUND DEBRIDEMENT IN A LONG-TERM CARE SETTINGWaycaster, C. et al. | 2011
-
PSY5 AN INVESTIGATION INTO THE RELATIONSHIP BETWEEN OBESITY AND SKIN AND SOFT TISSUE INFECTIONS REQUIRING HOSPITALIZATIONSwiney, J. et al. | 2011
-
PSY17 A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICOArocho, R. / Northridge, K. / Rivera Hurtado, R. / Garcí / a Chá / vez, J. et al. | 2011
-
PSY23 ECONOMIC EVALUATION OF ERYTHROPOIESIS STIMULATING AGENTS IN CRITICALLY ILL TRAUMA PATIENTSChui, B. K. / Hazel, M. / Dong, J. / Klarenbach, S. et al. | 2011
-
PSY49 PREDICTORS OF OBESITY TREATMENT (COUNSELING OR PHARMACOTHERAPY) IN AMBULATORY SETTINGSMehta, H. B. / Patel, J. / Parikh, R. / Abughosh, S. et al. | 2011
-
PSY57 DOES CLINICAL DIAGNOSIS OF OBESITY INCREASE THE LIKELIHOOD OF RECEIVING OBESITY RELATED COUNSELING? A 2005-2008 NAMCS-NHAMCS ANALYSISKadakia, A. / Mehta, H. / Rajan, S. S. / Abughosh, S. et al. | 2011
-
PSY63 LONGITUDINAL ANALYSIS OF INFLIXIMAB DOSING AND INFUSION INTERVALS ACROSS 30 INFUSIONSCarter, C. / Haas, S. / Gunnarsson, C. / Rizzo, J. / Ingham, M. et al. | 2011
-
PUK7 ECONOMIC EVALUATION OF CINACALCET VERSUS STANDARD TREATMENT IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM IN MEXICOArocho, R. / Ianazzo, S. / Rivera Hurtado, R. / Paniagua Sierra, J. R. et al. | 2011
-
PMD41 SELECTING A SECONDARY DATA SOURCE FOR A LOW-VOLUME PROCEDURE IN A SPECIALTY POPULATION: A STUDY USING INPATIENT PEDIATRIC COLONOSCOPYAnastassopoulos, K. P. / Knight, T. G. / Baik, R. et al. | 2011
-
PSU6 ANALYSIS OF FACTORS INFLUENCING INPATIENT MORTALITY AND COSTS AMONG PEDIATRIC HEART TRANSPLANTATION RECIPIENTSOlvey, E. L. / Nolan, P. E. / Skrepnek, G. et al. | 2011
-
PSU7 A DISCRETE EVENT SIMULATION MODEL TO ESTIMATE THE LONG TERM OUTCOMES OF BARIATRIC SURGERY IN MEXICOZanela, O. O. / Cabra, H. A. / Anaya, P. / Rodriguez, S. / Melendez, G. et al. | 2011
-
PSU12 IMMUNOSUPPRESSANT THERAPY ADHERENCE AND REJECTION OUTCOMES IN LIVER AND KIDNEY TRANSPLANT PATIENTSGorevski, E. / Minkara, A. / Bain, B. / Mogilishetty, G. / Martin Boone, J. et al. | 2011
-
PMH48 AMBER TODDTodd, A. M. / Zuckerman, I. H. et al. | 2011
-
PDB35 UTILIZATION OF PHYSICIAN, NURSING AND DIETICIAN SERVICES BY TYPE 2 DIABETIC PATIENTS ATTENDING PRIMARY CARE CLINICS IN SINGAPOREToh, M. P. / Wu, C. X. et al. | 2011
-
PDB42 ADHERENCE TO ROUTINE OR STRUCTURED GLUCOSE MONITORING: A QUALITATIVE EVALUATION FROM THE STEP STUDYBergstrom, F. / Whittemore, R. / Schaefer, C. / Christopher, C. A. / Amstutz, L. / Wagner, R. S. et al. | 2011
-
PDB55 CLINICAL AND ECONOMIC EVALUATION OF A DIABETES MEDICATION MANAGEMENT PROGRAM: 2 YEAR PROGRAM UPDATEGorsh, B. / Kim, Y. / Prasla, K. / Tabor, T. / Chaddick, J. / Godley, P. J. et al. | 2011
-
PIH21 COST-UTILITY ANALYSIS OF DIENOGEST VERSUS GNRH ANALOGUE IN THE TREATMENT OF ENDOMETRIOSIS-ASSOCIATED PELVIC PAIN IN SLOVAKIALukac, M. / Knight, C. / Bielik, J. / Tomek, D. / Foltan, V. / Kovac, A. / Bojnicky, M. et al. | 2011
-
PIH31 SELF MEDICATION: ASSESSMENT OF STATUS, PRACTICES AND PERCEPTIONSaleem, F. / Azhar, S. / Al-Qazaz, H. K. / Ahmad, N. / Atif, M. / Haq, N. / Iqbal, Q. / Asif, M. et al. | 2011
-
PIN37 HOW MANY IMMUNIZATION DOSES WERE MISSED IN PEDIATRICES YOUNGER THAN 2 YEARS?Al-lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Basher, A. Y. et al. | 2011
-
PIN43 UTILIZATION AND SPENDING OF ANTIFUNGAL AGENTS IN THE UNITED STATES OUTPATIENT MEDICAID POPULATION: 1991-2009Desai, V. C. / Cavanaugh, T. / Guo, J. J. et al. | 2011
-
PIN50 CARE ORGANIZATION AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONS FOR BACTERIAL PNEUMONIAObi, E. N. / Thomas, J. et al. | 2011
-
PMS1 DO BISPHOSPHONATES CAUSE ATYPICAL FEMUR FRACTURES?Mann, J. / Talbert, J. et al. | 2011
-
PMS2 ATRIAL FIBRILLATION IN OSTEOPOROTIC WOMEN TREATED WITH ALENDRONATEChang, L. C. / Kao, Y. H. / Hsiao, F. Y. / Tsai, Y. W. / Huang, W. F. et al. | 2011
-
PMS5 PERSISTENCE WITH BISPHOSPHONATE THERAPY AND RISK OF HIP FRACTUREChodick, G. / Shalev, V. / Sharon, Y. / Goldstein, I. et al. | 2011
-
PMS14 DIRECT HEALTHCARE COSTS ASSOCIATED WITH OSTEOARTHRITISLe, T. K. / Montejano, L. B. / Cao, Z. / Zhao, Y. / Ang, D. et al. | 2011
-
PMS29 COST-UTILITY ANALYSIS OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, LIMITED FASCIECTOMY, AND PERCUTANEOUS NEEDLE FASCIOTOMY IN DUPUYTREN'S CONTRACTURESau, C. / Bounthavong, M. / Tran, J. N. / Wilson, R. L. et al. | 2011
-
PMS41 PATIENT BURDEN OF GOUT: RESULTS FROM THE UNITED STATES NATIONAL HEALTH AND WELLNESS SURVEY (NHWS)Khanna, P. / Forsythe, A. / Annunziata, K. / Khanna, D. et al. | 2011
-
PMS44 ASSESSING VITALITY IN PATIENTS UNDERGOING ETANERCEPT THERAPY FOR RHEUMATOID ARTHRITISGandra, S. R. / Vernon, M. / Cole, J. C. / Bitman, B. / Park, G. S. / Wang, B. / Chaudhari, S. / Fleischmann, R. M. et al. | 2011
-
PMS60 PATIENT OUTCOMES ASSOCIATED WITH BIOLOGIC INFUSION SITE OF CARE FOR THE TREATMENT OF RHEUMATOID ARTHRITISBolge, S. / Ingham, M. / Gupta, S. et al. | 2011
-
PRS10 COST ANALYSIS OF VARENICLINE VERSUS NICOTINE REPLACEMENT THERAPY AND UNAIDED CESSATION IN NICARAGUALutz, M. / Lovato, P. / Cuesta, G. et al. | 2011
-
PRS14 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEXICOBriones, B. / Zuñ / iga, G. / Garcí / a-Contreras, F. et al. | 2011
-
PRS15 ECONOMIC EVALUATION OF FLUTICASONE FUROATE COMPARED WITH MOMETASONA FUROATE FOR THE PRIMARY TREATMENT OF ALLERGIC RHINITIS PATIENTSRely, K. / Alexandre, P. K. / Anaya, P. / Salinas Escudero, G. et al. | 2011
-
PRS19 COST-UTILITY OF VARENICLINE VERSUS INTERVENTIONS AVAILABLE FOR QUITTING SMOKING IN PANAMA USING THE BENESCO MODELLutz, M. / Lovato, P. / Penna, M. / Cuesta, G. et al. | 2011
-
PRS41 A REAL-WORLD EVALUATION OF BETA AGONIST USE DURING HOSPITALIZATIONS FOR COPDRobinson, S. B. / Sarocco, P. / Karafilidis, J. / Walsh, J. / Johnson, B. H. / Ernst, F. R. et al. | 2011
-
PRM3 THE BURDEN OF CAREGIVING: ASSESSING THE STATUS OF CURRENT CLINICAL RESEARCHHamer, N. / Costello, S. / Roper, S. / Hamerslag, L. et al. | 2011
-
PRM5 A REVIEW AND CLASSIFICATION OF CONTINGENT VALUATION METHOD STUDIES IN SUB-SAHARA AFRICAKangethe, A. W. / Franic, D. et al. | 2011
-
PRM14 VALIDATING AN ONLINE CALCULATOR FOR EVALUATING HEALTH INTERVENTION OPTIONS USING THE ANALYTIC HIERARCHY PROCESS (AHP)McGhan, W. F. / Vichaichanakul, K. / Willey, V. J. et al. | 2011
-
PRM10 IS IT FEASIBLE TO COLLECT QUALITY OF LIFE DATA ELECTRONICALLY IN THIN - A UK GENERAL PRACTICE DATABASE?Blak, B. T. / Lee, J. / Thompson, M. / Bourke, A. / Pinder, L. et al. | 2011
-
PRM37 THE DISCRETE MODELLING OF INTERVENTIONS WITH CONTINUOUSLY VARYING COSTS AND EFFECTS: IMPLICATIONS FOR ICERS, CEACS AND EVPIO'Mahony, J. / van Rosmalen, J. et al. | 2011
-
PCN9 VALUE OF RESEARCH ANALYSES IN RESEARCH PRIORITIZATION OF CANCER GENOMIC APPLICATIONSCarlson, J. / Thariani, R. / Roth, J. / Ramsey, S. / Deverka, P. / Esmail, L. / Gralow, J. / Henry, N. L. / Veenstra, D. et al. | 2011
-
PCN30 DOES A LACK OF HTA REVIEW LEAD TO HIGHER PRICES FOR HIV TREATMENTS? A COMPARISON WITH ONCOLOGY TREATMENTSNordyke, R. / Imbeah-Ampiah, R. / Ng-Haing, J. / Oshinowo, B. / Saraf, S. et al. | 2011
-
PCN47 ACUTE LYMPHOCYTIC LEUKEMIA-RELATED INPATIENT CARE AMONG PEDIATRIC PATIENTS IN THE UNITED STATESMitra, D. / Candrilli, S. D. et al. | 2011
-
PCN56 COST-EFFECTIVENESS OF TEMSIROLIMUS FOR METASTIC RENAL-CELL CARCINOMA AND POOR PROGNOSIS PATIENTS IN MEXICOArreola-Ornelas, H. / Rosado-Buzzo, A. / Garcia-Mollinedo, M. / Camacho, L. / Mould-Quevedo, J. F. / Muciñ / o-Ortega, E. / Galindo-Suarez, R. M. et al. | 2011
-
PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION TESTING AND FIRST LINE TREATMENT WITH GEFITINIB IS A DOMINANT STRATEGY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)de Lima Lopes, G. et al. | 2011
-
PCN75 ECONOMIC EVALUATION OF DASATINIB IN CHRONIC MYELOGENOUS LEUKAEMIA PATIENTS RESISTANT TO IMATINIB IN PERU, COMPARED TO NILOTINIB AND HIGH DOSES OF IMATINIBOrozco Giraldo, J. J. / Valencia, J. E. / Garrido Lecca, S. / Aiello, E. C. et al. | 2011
-
PMH2 RISK OF HOSPITALIZATION FOR PNEUMONIA ASSOCIATED WITH THE USE OF ATYPICAL VERSUS TYPICAL ANTIPSYCHOTICS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIESDharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. et al. | 2011
-
PMH12 THE PROFILE OF IMPAIRMENTS TO ATTENTION AND EPISODIC RECOGNITION MEMORY IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASEWesnes, K. / Lenderking, W. R. et al. | 2011
-
PMH26 MEDICATION ADHERENCE AND HEALTH CARE COSTS AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINEZhao, Y. / Cui, Z. / Fang, Y. / Faries, D. et al. | 2011
-
PMH77 UTILIZATION PATTERN OF PSYCHOTHERAPY AS AN ADJUNCT TO PHARMACOTHERAPY AMONG AMBULATORY BIPOLAR DISORDER PATIENTSMehta, S. / Bhattacharya, R. / Aparasu, R. R. et al. | 2011
-
PMH85 A SCHIZOPHRENIA OR BIPOLAR TYPE I DISORDER REGISTRY: LESSONS LEARNED FROM CONDUCTING A REGISTRY STUDY WITH SAFETY NET PROVIDERSPanish, J. / Dirani, R. / Mark, T. / Montejano, L. B. / Starr, H. L. / Mao, L. et al. | 2011
-
PND26 MEASURING THE IMPACT OF NATALIZUMAB THERAPY ON HEALTH CARE UTILIZATION IN A COMMERCIALY MANAGED MULTIPLE SCLEROSIS POPULATIONPill, M. / Gilkin, B. et al. | 2011
-
PND29 VALIDATION OF THE HUNTINGTON CLINICAL SELF-REPORTED INSTRUMENT (H-CSRI), A CLINIMETRIC PATIENT ASSESSED SCALE FOR PATIENTS WITH HUNTINGTON'S DISEASEClay, E. / Dorey, J. / Toumi, M. / Tedroff, J. / Squitieri, F. / De Nicola, N. / Verny, C. et al. | 2011
-
PND34 MAPPING THE INSOMNIA SEVERITY INDEX (ISI) TO THE EQ-5D UTILITIESGu, N. Y. / Ji, X. / Bell, C. / Botteman, M. et al. | 2011
-
PND40 ASSESSMENT OF PERCEIVED SEVERITY OF DISEASE AND SYMPTOMS, QUALITY OF LIFE, WORK PRODUCTIVITY, AND HEALTH CARE RESOURCE USE IN INDIVIDUALS WITH MULTIPLE SCLEROSISPhillips, A. / Stewart, M. / Edwards, N. / Gupta, S. / Goren, A. et al. | 2011
-
PND47 THE HEMOPHILIA UTILIZATION GROUP STUDY (HUGS-VB): HEALTH-RELATED QUALITY OF LIFE IN HEMOPHILIA BPoon, J. L. / Lou, M. / Doctor, J. / Zhou, Z. Y. / Gwadry-Sridhar, F. / Baker, J. / Ullman, M. / Koerper, M. / Johnson, K. et al. | 2011
-
PND58 INPATIENT HEALTH RESOURCE UTILIZATION AMONG MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEMTakemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Santos, P. M. / Duarte, G. G. / Moretti, A. I. et al. | 2011
-
CN1 MONOTHERAPY OF ANDROGEN DEPRIVATION THERAPY VERSUS RADICAL PROSTATECTOMY AMONG VETERANS WITH LOCALIZED PROSTATE CANCER: A COMPARATIVE EFFECTIVENESS ANALYSIS OF RETROSPECTIVE COHORTSLiu, J. / Shi, L. / Sartor, O. et al. | 2011
-
CO3 PROJECT LIBRA: A NEW ANALYTIC TOOL FOR COMPARATIVE EFFECTIVENESS ANALYSES OF MULTIPAYER CLAIMS DATABASESMark, T. / Pepitone, A. / Hatzmann, M. / Navathe, A. / Goodrich, K. / Chang, S. et al. | 2011
-
DU1 COMPARATIVE SAFETY OF STIMULANT AND ATOMOXETINE ASSOCIATED WITH THE RISK OF SUBSTANCE USE DISORDER AMONG ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDERBhattacharjee, S. / Chen, H. / Bhatara, V. / Aparasu, R. R. et al. | 2011
-
IN1 MEASUREMENT OF SYMPTOMS AND IMPACT OF INFLUENZA: DEVELOPMENT OF THE SYMPTOM INTENSITY AND IMPACT OF INFLUENZA QUESTIONNAIRE (FLU-IIQ)Osborne, R. H. / Norquist, J. / Elsworth, G. / Busija, L. / Mehta, V. / Herring, T. / Gupta, S. et al. | 2011
-
IN4 CARDIOVASCULAR DISEASE SCREENING IN HIV-INFECTED PATIENTS – A COST-EFFECTIVENESS ANALYSISNolte, J. E. / Neumann, T. / Neumann, A. / Manne, J. / Mostardt, S. / Abbara, S. / Brady, T. J. / Hoffmann, U. / Gazelle, G. S. / Wasem, J. et al. | 2011
-
EV2 PAYERS AND PROS: BEYOND QOLMiller, K. L. / Stevens, C. A. et al. | 2011
-
PHP3 FEDERAL ENFORCEMENT ACTIONS AGAINST FRAUD AND ABUSE BY PHARMACEUTICAL MANUFACTURERS: 1996-2010Qureshi, Z. / Sartor, O. / Bennett, C. et al. | 2011
-
PHP27 CANADIAN PUBLIC DRUG PROGRAM SPENDING ON SENIORS, 2002 TO 2008Hunt, J. / Gaucher, M. et al. | 2011
-
PHP37 A REGISTRY PERSPECTIVE OF OF HOSPITAL DISCHARGE COSTS: PILOT RESULTS OF THE 10 MOST FREQUENT DIAGNOSIS AND PROCEDURES OF THE ARGENTINE-HEALTH CARE COST AND UTILIZATION PROJECT (A-HCUP)Insua, J. T. / Giunta, D. / Ioli, P. / Villalon, R. et al. | 2011
-
PHP54 THE IMPACT OF PHARMACIST-CONDUCTED MEDICATION RECONCILIATION WITH PATIENT COUNSELING AT HOSPITAL ADMISSIONChen, C. C. / Huang, Y. F. / Ho, S. W. / Lu, S. H. / Lin, H. Y. / Liu, H. P. et al. | 2011
-
PHP67 UNDERSTANDING THE VIETNAMESE PRICING AND REIMBURSEMENT ENVIRONMENT THROUGH A COMPARISON WITH THAT OF CHINALewis, S. / Dummett, H. et al. | 2011
-
PHP76 THE OUTLOOK OF LARGE SIMPLE TRIALS FOR COMPARATIVE EFFECTIVENESS RESEARCH: AN APPLICATION OF THE PRECIS FRAMEWORKVincent, L. et al. | 2011
-
DM4 EVALUATION OF CLINICAL LABORATORY-PHARMACY LINKAGE DECISION SUPPORT IN THE USE OF POTASSIUM SUPPLEMENTSYu, S. / Galanter, W. / Lin, F. J. / Lambert, B. et al. | 2011
-
OR4 ASSOCIATIONS BETWEEN JOBLESSNESS AND ALL-CAUSE HEALTH SERVICES UTILIZATION IN DIABETIC WORKING AGE ADULTS IN THE UNITED STATESDavis-Ajami, M. L. / Nahata, M. / Seiber, E. / Reardon, G. / Balkrishnan, R. et al. | 2011
-
CE2 A NOVEL WAY OF ESTIMATING COST-EFFECTIVENESS RATIOS FROM CLINICAL TRIALS WITH MISSING DATA: A SIMULATION STUDYGagnon, D. D. / Engelhart, L. et al. | 2011
-
MC1 COMPARISON OF REFILL GAP ANALYSIS METHODOLOGIES IN A POPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB OR ETANERCEPTCarter, C. / Bolge, S. / Ingham, M. / Schmeichel-Mueller, C. et al. | 2011
-
MD2 PRESCRIPTION DRUG COST AND USE IN THE MEDICARE PART D POPULATION - USES OF A NEW LIMITED DATA SETPowers, C. A. / Varghese, A. / Hsu, V. D. / O'Donnell, J. / Schneider, K. et al. | 2011
-
PHP6 EXPLORE THE USE OF DRUGS IN MEDICAL INSURANCE BILLING IN CHINATan, Z. et al. | 2011
-
PHP19 TRENDS IN ON-LABEL AND OFF-LABEL PRESCRIBING OF MONTELUKAST IN A COMMERCIALLY INSURED POPULATION 1998-2008Ali, M. M. / Martin, B. et al. | 2011
-
PHP22 ASSOCIATION OF SELF-REPORTED HEALTH STATUS WITH COST-RELATED MEDICATION NONADHERENCE AND OUT-OF-POCKET PHARMACY SPENDING AMONG SENIOR MEDICARE BENEFICIARIESTang, Y. et al. | 2011
-
PHP43 THE INFLUENCE OF PATIENT ACCESS SCHEMES ON APPRAISAL DECISIONS BY NICE IN THE UNITED KINGDOMTimm, B. / Kusel, J. / Hamer, N. / Costello, S. et al. | 2011
-
PHP44 DURATION OF PATIENTS VISITS TO THE EMERGENCY DEPARTMENTKaraca, Z. / Wong, H. / Mutter, R. et al. | 2011
-
PHP56 DEMONSTRATING CLINICAL-EFFECTIVENESS USING INDIRECT AND MIXED TREATMENT COMPARISON ANALYSIS: A REVIEW OF MANUFACTURERS' SINGLE TECHNOLOGY APPRAISAL (STA) SUBMISSIONS TO THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)Bending, M. W. / Hutton, J. / McGrath, C. et al. | 2011
-
PHP65 HEALTH OUTCOMES AND ECONOMICS RESEARCH FOR CELLULAR THERAPIES AND REGENERATIVE MEDICINES: LESSONS FROM A HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT ANALYSIS IN THE UNITED STATESFaulkner, E. C. / Spinner, D. S. et al. | 2011
-
PHP75 USE OF ELECTRONIC MEDICAL RECORDS FROM 2001 THROUGH 2010: IMPLICATIONS FOR COMPARATIVE EFFECTIVENESS RESEARCHAnastassopoulos, K. P. / Mann, R. / Knight, T. G. / Sudharshan, L. / Ackerman, S. J. et al. | 2011
-
PHP81 CAREGIVER WELL-BEING AND HEALTH CARE ACCESS AND QUALITY AMONG CHILDREN WITH CHRONIC PHYSICAL AND MENTAL CONDITIONSRane, P. / Sambamoorthi, U. et al. | 2011
-
PCV7 ANALYSIS OF TREATMENT PATTERNS AND COSTS FOR VENOUS THROMBOEMBOLISM, MAJOR AND MINOR BLEEDING EVENTS IN HOSPITALIZED MEDICALLY ILL PATIENTSBaser, O. / Xie, L. / Du, J. / Wang, L. et al. | 2011
-
PHP114 OPTIMIZING THE ORGANIZATION; MIGRATING HEALTH SERVICES RESEARCH OPERATIONS INTO THE COLLABORATIVE SCIENCE CENTER OF EXCELLENCEBenson, J. / Enterline, L. et al. | 2011
-
PCV12 IMPACT OF POTENTIAL DRUG-DRUG INTERACTIONS (DDIS) ON HEALTH OUTCOMES AND COST TO MEDICAID: THE MONETARY BENFITS OF QUALITY HEALTH CAREAthavale, A. S. / Banahan, B. F. / Mendonca, C. M. et al. | 2011
-
PCV17 PREDICTORS OF TIME TO DISCONTINUE BETA-BLOCKER FOLLOWING ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE MEDICARE 5% NATIONAL SAMPLE DATA 2006-2007Lokhandwala, T. / Yang, Y. / Thumula, V. / Bentley, J. P. / Strum, M. / Banahan, B. F. / Null, K. et al. | 2011
-
PCV26 EFFECTS OF THIAZOLIDINEDIONES ON CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS AFTER DRUG-ELUTING STENT IMPLANTATIONYeh, S. Z. / Hsieh, C. F. / Tsai, Y. W. / Huang, W. F. et al. | 2011
-
PCV49 COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENTVorobyev, P. / Krasnova, L. / Borisenko, O. / Lukyantseva, D. / Bashlakova, E. et al. | 2011
-
PCV112 EXTENSION OF META-ANALYSIS IN COMPARING OF FIMASARTAN WITH LOSARTAN IN BLOOD PRESSURE LOWERING EFFECTNa, Y. / Lee, E. K. et al. | 2011
-
PSS12 A DISCRETE EVENT SIMULATION TO OPTIMISE THE ALLOCATION OF CONSTRAINED HOSPITAL RESOURCES FOR GLAUCOMACrane, G. J. / Karnon, J. / Kymes, S. / Casson, R. / Metcalfe, A. / Hiller, J. E. et al. | 2011
-
PSS16 DEVELOPMENT OF A DISEASE SPECIFIC VERSION OF THE EQ-5D FOR USE IN PSORIASISLloyd, A. / Swinburn, P. / Boye, K. S. / Edson, E. / Bowman, L. et al. | 2011
-
PSS26 PATIENT'S EVALUATION OF THE QUICKNESS OF ACTION OF GINGIVAL INFLAMMATION TREATMENTSMattout, P. / Rahhali, N. / Watt, M. / Auges, M. / Taieb, C. et al. | 2011
-
PSS23 COMPARING HEALTH-RISK BURDEN AND TOTAL HEALTHCARE COSTS OF PSORIASIS WITH TOP FIVE CHRONIC CONDITIONSNaim, A. / Pitts, J. / Chen, C. Y. / Wright, D. / Chalk, M. B. / Edington, D. et al. | 2011
-
PSY22 ANALYSING THE BENEFITS AND COST SAVING OF ORAL VERSUS IV FLUDARABINE FOR MANAGEMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)Zinzani, P. L. / Connors, J. M. / Knight, A. D. / Crowe, A. M. / Jones, R. / Tucker, B. et al. | 2011
-
PSY28 FACTORS LEADING TO HIGH HEALTH CARE EXPENDITURE AMONG OBESE INDIVIDUALS IN THE UNITED STATESPatel, J. G. / Aparasu, R. R. / Rajan, S. S. / Johnson, M. L. et al. | 2011
-
PSY62 PERCEIVED BENEFITS AND DISADVANTAGES OF INTRAVENOUS (IV) BIOLOGIC THERAPY AMONG PATIENTS WITH IMMUNOLOGY CONDITIONSBolge, S. / Vanderpoel, J. / Eldridge, H. / Mody, S. / Lofland, J. / Ingham, M. et al. | 2011
-
PSY72 VARIATION BY AGE IN HEALTH-RELATED QUALITY OF LIFE OF PATIENTS INITIATING TREATMENT FOR MYELODYSPLASTIC SYNDROMESPashos, C. / Grinblatt, D. L. / Komrokji, R. S. / Sekeres, M. A. / Narang, M. / Sullivan, K. A. / Street, T. K. / Khan, Z. M. et al. | 2011
-
PSY76 TREATMENT OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS) KNOWLEDGE STUDY (TOCKS): NOVEL DATA COLLECTION, VIEWING AND DYNAMIC REPORTING MECHANISMArnold, R. J. / Groesser, K. et al. | 2011
-
PUK10 KIT73 STUDY: RELATIONSHIP BETWEEN COSTS OF CARE AND 12-MONTH GLOMERULAR FILTRATION RATES IN POST-KIDNEY TRANSPLANT PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)David-Neto, E. / Esmeraldo, R. M. / Asano, E. / Nita, M. E. / Nishikawa, A. M. / Barbosa, E. / Szabo, S. M. / Levy, A. R. / Carvalho, J. F. / Donato, B. M. et al. | 2011
-
PUK18 THE IMPACT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) ON PATIENTS' HEALTH RELATED QUALITY OF LIFE (HRQOL): DEVELOPMENT OF A CONCEPTUAL FRAMEWORKCole, J. C. / Krasa, H. B. / Cheng, R. / Oberdhan, D. / Urwongse, J. / Schaefer, C. / Czerwiec, F. et al. | 2011
-
PMD25 THE COST-UTILITY AND VALUE OF INFORMATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARED TO STANDARD MANAGEMENT AND SURGICAL AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSISDoble, B. M. / Perampaladas, K. / von Keyserlingk, C. / Campbell, K. / Blackhouse, G. / Goeree, R. / Xie, F. et al. | 2011
-
PSU5 LONG-TERM CLINICAL SAFETY OF LASIK AND SURFACE ABLATION IN SOUTH KOREA THROUGH LINKAGE OF RETROSPECTIVE COHORT AND NATIONWIDE CLAIMS DATABASELee, E. J. / Choi, J. E. / Jung, S. Y. / Jang, E. J. / Lee, N. R. / Joo, C. K. et al. | 2011
-
PSU23 ASSESSING THE OUTCOME OF SHOULDER SURGERY: DEVELOPMENT, VALIDATION AND RESPONSIVENESS OF THE PATIENT-REPORTED OXFORD SHOULDER SCORE (OSS)Dawson, J. / Fitzpatrick, R. / Carr, A. J. / Churchman, D. et al. | 2011
-
PSU24 AGREEMENT BETWEEN PROMIS DEPRESSION, SLEEP DISTURBANCE, AND FATIGUE CAT MEASURES AND SF-36 SCORES IN A CLINICAL COHORTNerenz, D. R. / Pietrantoni, L. / Schultz, L. / Obeid, L. / Swartz, A. / Rubinfeld, I. / Velanovich, V. et al. | 2011
-
PDB4 MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETESGaebler, J. A. / Soto-Campos, G. / Alperin, P. E. / Hoogwerf, B. J. / Wintle, M. / Maggs, D. / Han, J. / Blickensderfer, A. / Pencek, R. / Bruhn, D. et al. | 2011
-
PDB13 USE OF ANTIDEPRESSANTS AND THE RISK OF DIABETES MELLITUS: A RETROSPECTIVE COHORT STUDYKhoza, S. / Barner, J. C. / Lawson, K. / Rascati, K. L. / Wilson, J. P. / Bohman, T. M. et al. | 2011
-
PDB26 ECONOMIC EVALUATION OF GLIMEPIRIDE AND GLIMEPIRIDE/METFORMIN FOR TYPE-2 DIABETES MELLITUS IN MEXICOCarlos, F. / Lemus, A. et al. | 2011
-
PDB44 A NOVEL APPROACH FOR NON-ADHERENCE MEASUREMENT BASED ON PRESCRIPTION DATA: THE EXAMPLE OF ORAL DIABETICS IN THE THERAPY OF TYPE-2 DIABETES MELLITUS PATIENTSWilke, T. / Mueller, S. / Lindner, R. / Ahrens, S. / Verheyen, F. et al. | 2011
-
PDB45 THE PATIENT REPORTED EXPERIENCE OF LIVING WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN (DPNP)Brod, M. / Carson, R. / Ramasamy, A. / Setyawan, J. et al. | 2011
-
PDB52 A LITERATURE REVIEW OF DIABETES RISK ASSESSMENT TOOLSThoopputra, T. / Li, S. / Newby, D. / Schneider, J. et al. | 2011
-
PDB68 ASSESSING LIFEYEARS SAVED FROM 2000 TO 2010 IN CHINA DUE TO NOVO NORDISK INSULINHenriksen, O. / Jain, P. / Nielsen, O. K. et al. | 2011
-
PIH2 LEAD DETOXIFYING EFFECT OF VITAMIN C IN TRAFFIC POLICE SUBJECTSGilani, A. H. / Fazal, O. / Shah, A. J. / Mehmood, M. H. / Tariq, S. A. et al. | 2011
-
PIH10 HEALTH CARE RESOURCE UTILIZATION AND COSTS IN FEMALES WITH NEWLY DIAGNOSED HEAVY MENSTRUAL BLEEDING: AN EMPLOYER'S PERSPECTIVEJensen, J. T. / Lefebvre, P. / Laliberté / F. / Sarda, S. P. / Law, A. / Pocoski, J. / Duh, M. S. et al. | 2011
-
PIH8 THE ECONOMIC IMPACT ATTRIBUTABLE TO THE INAPPROPRIATE PRESCRIPTION OF BENZODIAZEPINES IN THE ELDERLY LIVING IN THE COMMUNITYDionne, P. A. / Vasiliadis, H. M. / Pré / ville, M. et al. | 2011
-
PIH30 POSTPARTUM DEPRESSION IN VULNERABLE PEOPLE IN SOUTH KOREAKim, B. H. / Choi, J. E. / Jeon, H. W. / Kim, J. A. / Sim, Y. H. / Kim, S. H. / Lee, K. J. / Jung, B. Y. / Kim, J. K. / Lee, D. S. et al. | 2011
-
PIH34 IMPLEMENTATION OF A STATE MEDICAID PRESCRIPTION CAP POLICY: IS THERE AN IMPACT ON BENEFICIARIES' MEDICAL SERVICES UTILIZATION AND COSTS?Khanna, R. / Dharmarajan, S. H. / Null, K. D. / Bentley, J. P. / Pace, P. F. / Banahan, B. F. et al. | 2011
-
PIN4 EFFICACY AND SAFETY OF THE COMBINATION EFAVIRENZ (EFV), TENOFOVIR (TDF) AND EMTRICITABINE (FTC) ONCE A DAY IN TREATMENT OF NAïVE ADULT PATIENTS WITH HIV-1 INFECTION: A SYSTEMATIC REVIEWRizzoli-Cordoba, A. / Delgado-Ginebra, I. et al. | 2011
-
PIN26 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF BACTEREMIA AND INFECTIVE ENDOCARDITIS IN PATIENTS WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION IN MEXICOGarcí / a-Contreras, F. / Martinez Revelles, M. / Briones, B. et al. | 2011
-
PIN30 COST EFFECTIVENESS ANALYSIS OF THE COMBINATION EFAVIRENZ (EFV), TENOFOVIR (TDF) AND EMTRICITABINE (FTC) ONCE A DAY IN TREATMENT OF NAïVE ADULT PATIENTS WITH HIV INFECTION IN MEXICORizzoli-Cordoba, A. / Delgado-Ginebra, I. / Pizarro-Castellanos, M. / Castillo, J. J. et al. | 2011
-
PMS7 THE IMPACT OF RHEUMATOID ARTHRITIS ON CARDIOVASCULAR MORBIDITY IN A HIGH RISK MEDICAID POPULATIONShaya, F. T. / Yan, X. / Johnson, W. R. et al. | 2011
-
PMS20 HEALTH CARE RESOURCES UTILIZATION IN THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS: ANALYSES WITH THE RAMQ DATABASELachaine, J. / Beauchemin, C. / Martel, M. J. / Goyette, A. et al. | 2011
-
PMS45 WILLINGNESS TO PAY FOR OSTEOPOROSIS TREATMENT TO PREVENT FRACTURE IN KOREAN POPULATIONSuh, H. S. / Kim, Y. / Park, J. / Park, S. / Hyun, M. K. / Ahn, J. et al. | 2011
-
PMS48 IMPACT OF ANTI-TNF ON HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ALBERTA, CANADAOhinmaa, A. / Thanh, N. X. / Martin, L. / Russell, A. / Barr, S. / Shelter, D. / Penney, C. / Yan, C. / Maksymowych, W. et al. | 2011
-
PMS52 PREDICTORS OF BISPHOSPHONATE PRESCRIPTION IN PATIENTS WITH OSTEOPOROSISPatel, A. V. / Wu, I. H. / Ho, L. / Aparasu, R. R. et al. | 2011
-
PRS21 RESOURCE USE AND COSTS OF EXACERBATION MANAGEMENT OF CHRONIC OBSTRUTIVE PULMONARY DISEASE PATIENTS UNDER THE PRIVATE HEALTHCARE SYSTEM IN BRAZIL: ROLE OF MAINTENANCE TREATMENT IN THE EXACERBATION PREVENTION IN SEVERE PATIENTSNasciben, V. et al. | 2011
-
PRM38 THE EXTENSION OF THE COST-EFFECTIVENESS ACCEPTABILITY CURVE: HOW TO MAKE IT MORE INFORMATIVE?Kamae, I. / Araki, D. / Kamae, M. et al. | 2011
-
PCN21 PATTERNS OF ANGIOGENESIS INHIBITOR TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN IRELANDMcDermott, R. / Donnellan, P. / McCaffery, J. / Keane, F. / Sarda, S. P. / Korves, C. / Luka, A. / Wei, R. / Neary, M. P. / Hanley, R. et al. | 2011
-
PCN29 TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING RITUXIMAB (R) WITH FLUDARABINE (F) AND CYCLOPHOSPHAMIDE (C): ASSESSING THE FINANCIAL IMPACT OF THE ROUTE OF ADMINISTRATION AT PRINCESS MARGARET HOSPITAL (PMH)Douglas, P. / Lee, R. / Worthington, K. / Mistry, B. et al. | 2011
-
PCN38 FIRST-YEAR COSTS FOR THE 19 MOST COMMON CANCER DIAGNOSES IN ONTARIOde Oliveira, C. / Bremner, K. / Chan, K. / Gunraj, N. / Krahn, M. et al. | 2011
-
PCN41 FINANCIAL BURDEN AMONG PATIENTS WITH MAJOR CANCERS: FINDINGS FROM THE UNITED STATES MEDICAL EXPENDITURE PANEL SURVEY, 1996-2007Lang, K. / Huang, H. / Rodriguez, L. / Menzin, J. et al. | 2011
-
PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCERNguyen, T. T. / Yagudina, R. / Kulikov, A. U. et al. | 2011
-
PCN83 A COMPARISON OF PREFERENCES FOR TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMAPark, M. H. / Lee, E. K. et al. | 2011
-
PCN108 CLINICAL EFFICACY AND ONCOLOGY REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE INTERIM JOINT ONCOLOGY DRUG REVIEW (IJODR)Ciapanna, C. C. / Shum, D. / Milliken, D. / Yunger, S. et al. | 2011
-
PCN107 PAYER-RATED VALUE OF PAIN IMPROVEMENT IN CASTRATION-RESISTANT PROSTATE CANCER: TRADEOFFS BETWEEN SURVIVAL, PAIN AND ANALGESIC USESchneider, J. / Beusterien, K. / Ohsfeldt, R. / Brown, J. / Boye, M. E. / Ebeid, O. / Hill, J. et al. | 2011
-
PGI16 RESOURCE UTILIZATION AND HEALTH CARE COSTS ASSOCIATED WITH DIVERTICULAR DISEASE: RESULTS FROM A RETROSPECTIVE CLAIMS DATABASE ANALYSIS IN THE UNITED STATESYen, L. / Davis, K. / Longstreth, G. / Streck, P. / Hodgkins, P. et al. | 2011
-
PGI15 COST EFFECTIVENES OF THE PHARMACOLOGIC TREATMENT OF IRRITABLE BOWEL SYNDROME AT THE SOCIAL SECURITY MEXICAN INSTITUTEOjeda Mé / ndez, J. / Contreras, I. / Vallejos Pará / s, A. et al. | 2011
-
PMH13 COMPARATIVE EFFECTIVENESS STUDY OF RISPERIDONE LONG-ACTING INJECTABLE: THE USE OF DYNAMIC EXPOSURE METHODOLOGY FOR RISK SHARING AGREEMENTGrimaldi-Bensouda, L. / Rouillon, F. / Abenhaim, L. et al. | 2011
-
PMH18 IMPACT OF COGNITIVE IMPAIRMENT ON FUNCTIONING, MEDICAL RESOURCE UTILIZATION, ADHERENCE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIALin, F. J. / Bhor, M. / Hass, S. / Perry, R. / Kay, S. et al. | 2011
-
PMH20 PSYCHOTROPIC MEDICATION USE AMONG CHILDREN WITH AUTISM SPECTRUM DISORDER: A COMPARISON BETWEEN MEDICAID AND COMMERCIAL INSURANCEWang, L. / Leslie, D. et al. | 2011
-
PMH42 ECONOMIC EVALUATION OF DESVENLAFAXINE IN THE ACUTE MANAGEMENT OF ASSOCIATED MAJOR DEPRESSIVE DISORDER IN MEDICALLY ILL INPATIENTS FROM A BRAZILIAN PUBLIC GENERAL HOSPITAL PERSPECTIVEScaccabarozzi, L. / Takemoto, M. L. / Fernandes, R. A. / Santos, P. M. / Tolentino, A. C. et al. | 2011
-
PND12 LOWER DAILY AVERAGE CONSUMPTION AND GREATER PRESCRIPTION COST SAVINGS OF ARMODAFINIL COMPARED WITH MODAFINIL: A 12-MONTH RETROSPECTIVE DATABASE ANALYSISCarlton, R. / Regan, T. S. / Rice, G. et al. | 2011
-
PND30 QUALITY OF LIFE AMONG PATIENTS SUFFERING FROM MIGRAINE: HEALTH UTILITY BY FREQUENCY OF HEADACHE DAYSGillard, P. / Devine, B. / Bloudek, L. M. / Liu, L. / Varon, S. F. / Lipton, R. B. / Sullivan, S. D. et al. | 2011
-
PND49 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN PARKINSON'S DISEASEBanks, P. / Martin, C. R. et al. | 2011
-
PHP101 VALUE BASED PRICING: WHAT IS THE FUTURE FOR PATIENT ACCESS SCHEMES?Loveman, C. M. / Mallinson, M. / Areteou, T. / White, R. et al. | 2011
-
PHP107 BIOMARKERS: A CHANGING PARADIGM FOR DEVELOPMENTPardini, A. T. / Saraf, S. / Sparrowhawk, K. et al. | 2011
-
PCV35 COMPARISON OF MAJOR BLEEDING RELATED MORTALITY, HEALTH CARE UTILIZATION AND COSTS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATIONBaser, O. / Du, J. / Xie, L. / Baser, E. et al. | 2011
-
PCV60 MEDICATION ADHERENCE, PERSISTENCE, AND HEALTH CARE COSTS FOR PATIENTS INITIATING STATIN THERAPY IN A MANAGED CARE POPULATIONZhao, Z. / Peng, X. / Bae, J. P. / Dungey, J. / Faries, D. E. / Sponseller, C. A. / Wetmore, S. / Yu, C. Y. / LeNarz, L. A. et al. | 2011
-
PCV81 SUSTAINING CLINICAL OUTCOMES OVER 24 MONTHS: IS MEDICATION THERAPY MANAGEMENT (MTM) THE ANSWER?Pinto, S. L. / Jania, A. W. / Coehrs, B. / Riepenhoff, C. et al. | 2011
-
PCV87 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG ELDERLY PATIENTSZhao, Z. / Peng, X. / Bae, J. P. / Sponseller, C. A. / LeNarz, L. A. et al. | 2011
-
PSS1 STEVENS-JOHNSON AND RED MAN SYNDROME: A CASE REPORT ON ADVERSE DRUG REACTIONS OF SIMULTANEOUS USE OF PHENYTOIN AND VANCOMYCINKler, S. K. et al. | 2011
-
PSY4 TRENDS IN HYPONATREMIA MANAGEMENT AND ASSOCIATED OUTCOMES IN HOSPITAL SETTINGS: INTERIM RESULTS FROM AN OBSERVATIONAL, PROSPECTIVE, MULTI-CENTER, GLOBAL REGISTRY IN HOSPITALIZED PATIENTSDasta, J. F. / Amin, A. / Chiong, J. R. / Greenberg, A. / Hauptman, P. J. / Verbalis, J. G. et al. | 2011
-
PSY8 DIRECT AND INDIRECT COSTS OF PRIVATELY-INSURED PATIENTS TREATED WITH OXYMORPHONE EXTENDED-RELEASE OR OXYCODONE CONTROLLED-RELEASE TABLETSKirson, N. Y. / White, A. / Birnbaum, H. G. / Schiller, M. / Waldman, T. / Ben-Joseph, R. / Summers, K. et al. | 2011
-
PSY12 BASELINE CHARACTERISTICS AND PRE–INDEX TOTAL HEALTH CARE AND RHEUMATOID ARTHRITIS-RELATED COSTS IN PATIENTS RECEIVING GOLIMUMAB THERAPYCarter, C. / Tandon, N. / Smith, D. et al. | 2011
-
PSY25 RELATIONSHIP BETWEEN MONTHLY OUT-OF-POCKET HEALTHCARE COSTS AND WORK PRODUCTIVITY AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASENaim, A. / DiBonaventura, M. / Lofland, J. / Freedman, D. et al. | 2011
-
PSY43 HEALTH-RELATED QUALITY OF LIFE IN UKRAINE PATIENTS WITH HEREDITARY COAGULOPATHIESVorobyev, P. / Borisenko, O. / Zhulyov, Y. / Krasnova, L. / Bezmelnitsyna, L. et al. | 2011
-
PSY54 APPLICATION OF THE NON-LINEAR BLINDER-OAXACA DECOMPOSITION TO STUDY RACIAL/ETHNIC DISPARITIES IN ANTI-OBESITY MEDICATION USEMehta, H. B. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. L. et al. | 2011
-
PSY58 DISPARITY IN OBESITY MANAGEMENT: UNDER-TREATMENT AMONG ELDERLY POPULATIONShah, A. J. / Patel, J. G. / Rajan, S. S. / Abughosh, S. / Masilamani, S. et al. | 2011
-
PSY73 PAIN MEDICATION USE AND DETERMINANTS OF OPIOIDS PRESCRIBING IN THE UNITED STATES OUTPATIENT SETTINGSRasu, R. / Cunningham, L. / Sohraby, R. / Knell, M. et al. | 2011
-
PUK1 INCIDENCE AND 30-DAY MORTALITY OF COMMUNITY ACQUIRED PNEUMONIA (CAP) IN THE MEDICARE FEE-FOR-SERVICE (FFS) POPULATIONRubin, J. L. / Li, S. / Yu, H. / Dunning, S. / Sato, R. et al. | 2011
-
PUK21 PATIENT CHARACTERISTICS ASSOCIATED WITH INITIATION OF OVERACTIVE BLADDER (OAB) DISCUSSION WITH A PHYSICIANBotros, S. / Chen, C. I. / Bavendam, T. / Zou, K. H. / Goren, A. / Gupta, S. et al. | 2011
-
PMD4 PERCEPTION OF IRON DEFICIENCY IN CLINICAL PRACTICES: MULTIDISCIPLINARY FRENCH SURVEY (SUPFER SURVEY)Lasocki, S. / Luporsi, E. / Jamin, C. / Darne, B. / Mahi, L. / Marteau, P. et al. | 2011
-
PMD12 GENDER DIFFERENCES IN TOTAL KNEE ARTHROPLASTY (TKA) POSTOPERATIVE PAIN MANAGEMENT IN THE UNITED STATESGraver, R. M. / Domyahn, M. / Read, C. E. / Menzie, A. M. / Feinglass, S. R. et al. | 2011
-
PMD20 COST-EFFECTIVENESS ANALYSIS OF A NEW INDEX FOR PROSTATE CANCER DETECTIONNichol, M. B. / Wu, J. / An, J. J. / Huang, J. T. / Denham, D. / Frencher, S. K. / Jacobsen, S. J. et al. | 2011
-
PMD35 SHORT TERM OUTCOMES ASSOCIATED WITH A CHANGE IN REIMBURSEMENT FOR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASEHaley, J. / Rasu, R. et al. | 2011
-
PMD36 FAILURE OF INTERNATIONAL ORGANIZATION FOR STANDARDIZATION GUIDELINES TO REPORT CLINICALLY RELEVANT INFORMATION ABOUT POINT-OF-CARE INR DEVICE PERFORMANCEShermock, K. M. / Lavallee, D. M. / Streiff, M. B. et al. | 2011
-
PSU13 MORBID OBESITY AND HEALTH RELATED QUALITY OF LIFETayyem, R. / Ali, A. / Atkinson, J. / Martin, C. R. et al. | 2011
-
PDB1 TREATMENT PATTERNS AND OUTCOMES AMONG OLDER EXENATIDE BID USERS COMPARED TO INSULIN GLARGINE USERSGaebler, J. A. / Schultz, J. F. / Blickensderfer, A. / Wenten, M. / Riedel, A. / Harley, C. et al. | 2011
-
PDB23 THE IMPACT OF TREATMENT MODIFICATION ON HEALTHCARE EXPENDITURE IN PATIENTS WITH TYPE-2 DIABETES INITIATING EXENATIDE BID OR INSULIN GLARGINEPawaskar, M. / Bonafede, M. / Johnson, B. H. / Fowler, R. / Hoogwerf, B. J. et al. | 2011
-
PDB51 IMPROVING HEALTH INSURANCE AND PREVENTIVE EFFORT AMONG DIABETIC PATIENTS: THE COLOMBIAN EXPERIENCETrujillo, A. J. / Vecino-Ortiz, A. I. / Ruiz Gó / mez, F. / Steinhardt, L. C. et al. | 2011
-
PDB66 COSTS OF THE PHARMACEUTICAL PROGRAM TO TREAT T2DM PATIENTS FROM HIPERDIA: GOVERNMENT HEALTH CARE PROGRAM FOR DIABETES AND HYPERTENSION POPULATION UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEMNasciben, V. / Melo, T. G. et al. | 2011
-
PDB67 IT PROCESSES IN CLINICAL PRACTICES FOR DIABETES PATIENTS TYPE IIHuttin, C. / Atwood, S. et al. | 2011
-
PMH68 FDA REGULATIONS AND ANTIDEPRESSANT UTILIZATIONCampbell, C. J. / Pickard, A. S. / Schumock, G. T. et al. | 2011
-
PIH12 INPATIENT COSTS OF LOW BIRTH WEIGHT AND PRE-TERM INFANTS IN THE UNITED STATES IN 2008Meyers, J. / Meyers, S. R. et al. | 2011
-
PIH19 COSTS AND EFFECTS OF A MULTIFACETED INTERVENTION TO IMPROVE THE QUALITY OF CARE OF CHILDREN IN DISTRICT HOSPITALS IN KENYABarasa, E. W. / Cleary, S. / English, M. et al. | 2011
-
PIH24 RACIAL DISPARITIES IN MEDICATION UNDERUSE: THE ROLE OF PATIENT SATISFACTION WITH CARECampbell, C. / Halanych, J. H. / Safford, M. M. / Pisu, M. et al. | 2011
-
PIH28 FATIGUE MANAGEMENT: EXAMPLE AT WOMEN WORKING IN PHARMACYTaieb, C. / Auges, M. / Rahhali, N. et al. | 2011
-
PIN5 THE PREVALENCE AND ECONOMIC BURDEN OF HEPATITIS C VIRUS INFECTION IN CANADA AND LATIN AMERICA: A SYSTEMATIC REVIEWSzabo, S. M. / Donato, B. M. / Yuan, Y. / Bibby, M. / Jimenez-Mendez, R. / Levy, A. R. et al. | 2011
-
PIN10 ECOMOMIC EVALUATION OF DAPTOMYCIN COMPARE WITH STANDARD THERAPY IN THE TREATMENT OF STAPHYLOCOCCUS AUREUS BACTEREMIA WITH OR WITHOUT ENDOCARDITIS IN COLOMBIARosso, F. / Soto, R. / Ariza, J. G. / Rueda, J. D. / Rosselli, D. et al. | 2011
-
PIN22 COST-EFFECTIVENESS OF A CATCH-UP DOSE OF HEPATITIS B VACCINE IN COLOMBIAN ADOLESCENTSAlvis, N. / Romero, M. / Paternina, A. / De la Hoz, F. et al. | 2011
-
PIN25 COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF THE VARICELLA VACCINE IN COLOMBIADe la Hoz, F. / Alvis, N. / Gamboa, O. / Castañ / eda, C. / Paternina, A. et al. | 2011
-
PIN44 REAL-WORLD EVALUATION OF THE ECONOMIC IMPACT OF DURATION OF DRUG THERAPY IN THE TREATMENT OF HEPATITIS C VIRUS (HCV)McCombs, J. / Shin, J. / Hines, P. / Saab, S. / Yuan, Y. et al. | 2011
-
PIN51 IMPACT OF 2005 MEASLES OUTBREAK IN THE UNITED STATES ON IMMUNIZATION RATE AGAINST MEASLESDwibedi, N. / Cortina, J. et al. | 2011
-
PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATESBeaubrun, A. C. / Daugherty, J. B. et al. | 2011
-
PMS46 IMPACT OF ETANERCEPT ON WORK AND ACTIVITY IMPAIRMENT IN EMPLOYED PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITISWatson, C. / Cheng, A. / Hone, D. / Huang, B. / Bitman, B. / Huang, X. Y. / Gandra, S. R. et al. | 2011
-
PMS51 RACIAL DISPARITIES IN UTILIZATION OF BIOLOGIC AND DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN A CALIFORNIA MEDICAID POPULATION WITH RHEUMATOID ARTHRITISNichol, M. B. / Wu, J. / Harker, J. O. / Knight, T. K. / Wong, A. L. et al. | 2011
-
PMS58 BURDEN OF RHEUMATOID ARTHRITIS DISEASE FLARESBolge, S. / Tandon, N. / Ingham, M. / Gupta, S. et al. | 2011
-
PRS9 COMPARISON OF THE BURDEN AND COST DRIVERS OF COPD HOSPITALIZATION BETWEEN HISPANIC AND WHITE POPULATION IN THE UNITED STATESBorrego, M. / Roberts, M. / Petersen, H. / Kharat, A. A. / Blanchette, C. et al. | 2011
-
PRS40 TRENDS IN ANTIBIOTIC PRESCRIBING RATES IN AMBULATORY CARE SETTINGS FOR ADULTS IN THE UNITED STATES WITH NASOPHARYNGITIS, UPPER RESPIRATORY TRACT INFECTIONS AND BRONCHITIS FROM 2006 TO 2008Agrawal, R. / Shah, J. / Chopra, P. / Aparasu, R. R. et al. | 2011
-
PRM1 MEASURING COMORBIDITY: AN UPDATED CRITICAL REVIEW OF AVAILABLE METHODSHermansson, J. / Carlqvist, P. / Kennedy, K. / Pietri, G. et al. | 2011
-
PRS42 CONCOMITANT ASTHMA MEDICATION USE IN PATIENTS USING OMALIZUMAB: RESULTS FROM THREE LARGE INSURANCE CLAIMS DATABASESLafeuille, M. H. / Duh, M. S. / Zhang, J. / Wertz, D. / Gu, T. / Tang, J. / Lefebvre, P. et al. | 2011
-
PRM11 WHY ALGORITHM DOESN'T MATTER IN SYNDROMIC SURVEILLANCE: A COMPARISON OF SYNDROME CLASSIFICATION METHODSShin, J. / Strylewicz, G. / Doctor, J. et al. | 2011
-
PRM16 VALIDATION AND PSYCHOMETRIC EVALUATION OF A 5-ITEM MEASURE OF PERCEIVED SOCIAL SUPPORTMcCarrier, K. P. / Bushnell, D. M. / Martin, M. L. / Paczkowski, R. / Nelson, D. R. / Buesching, D. et al. | 2011
-
PRM19 NON-RESPONSE BIAS IN A SURVEY ASSESSING PATIENTS' MEDICATION AND HEALTH BELIEFSGadkari, A. / McHorney, C. / Pedan, A. / Gowda, N. et al. | 2011
-
PRM23 MEASURING THE IMPACT OF PREVIOUS TREATMENT CYCLES ON HEALTH UTILITY IN PATIENTS RECEIVING BOTULINUM TOXIN TYPE A (BONTA) IN A PROSPECTIVE OBSERVATIONAL COHORT STUDY: MOBILITY STUDYSimonyi, S. / Jog, M. / Wein, T. / Beauchamp, R. / Miller, R. / Ismail, F. / Bhogal, M. / Huang, B. et al. | 2011
-
PRM24 EXPLORING THE INTERRELATIONSHIP BETWEEN UNINTENTIONAL AND INTENTIONAL NONADHERENCE AMONG 24,071 ADULTS WITH CHRONIC DISEASEGadkari, A. / McHorney, C. et al. | 2011
-
PRM36 NONPARAMETRIC ESTIMATION OF INCREMENTAL COST EFFECTIVENESS RATIO ACCOUNTING FOR SKEWNESSBlough, D. K. et al. | 2011
-
PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A HOSPITAL OUTPATIENT SETTINGCraver, C. / Gayle, J. / Balu, S. / Buchner, D. et al. | 2011
-
PCN4 BODY MASS INDEX AND STAGE OF DIAGNOSIS OF OVARIAN CANCER: A SYSTEMATIC REVIEW AND META-ANALYSISBlieden, M. B. et al. | 2011
-
PCN54 INJECTION OF LONG-ACTING SOMATOSTATIN ANALOGS: A COST CONSEQUENCE ANALYSIS IN FRANCE, GERMANY, THE UNITED KINGDOM AND THE UNITED STATESRoze, S. / Kurth, H. / Maury le Breton, A. et al. | 2011
-
PCN55 RACIAL VARIATION IN THE COST-EFFECTIVENESS OF CHEMOTHERAPY FOR PROSTATE CANCERGrabner, M. / Onukwugha, E. / Jain, R. / Mullins, C. D. et al. | 2011
-
PCN80 PATIENT PREFERENCES FOR TOXICITIES ASSOCIATED WITH CHEMOTHERAPIES FOR ADVANCED BREAST CANCERBeusterien, K. / Grinspan, J. / Tencer, T. / Brufsky, A. / Visovsky, C. et al. | 2011
-
PCN104 HOSPITAL COSTS OF ADVERSE EVENTS IN PATIENTS RECEIVING TREATMENT FOR METASTATIC COLORECTAL CANCERFu, A. Z. / Zhao, Z. / Wang, S. / Gao, S. / Barber, B. / Liu, G. et al. | 2011
-
PCN123 A SYSTEMATIC REVIEW OF TREATMENT GUIDELINES FOR METASTATIC COLORECTAL CANCEREdwards, M. / Chadda, S. / Zhao, Z. / Barber, B. / Sykes, D. et al. | 2011
-
PCN125 MELODY BRASIL: TREATMENT PATTERNS AND ASSOCIATED COSTS OF METASTATIC MELANOMA PATIENTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)Stefani, S. / Schmerling, R. A. / Asano, E. / Nita, M. E. / Nishikawa, A. M. / Dias, K. M. / Donato, B. M. / Rahal, E. et al. | 2011
-
PMH8 EFFECT OF VARIOUS ANTIDEPRESSANT GROUPS ON BONE MINERAL DENSITY (BMD)Kurmanji, J. M. / Syed Sulaiman, S. A. / Chandrasekaran, P. K. / Kah, L. K. et al. | 2011
-
PMH15 IMPACT OF ADHERENCE TO FIRST THERAPY ON THE RISK OF ANTIDEPRESSANT SWITCHINGJung, S. Y. / Shin, S. / Song, H. / Park, J. / Ahn, J. et al. | 2011
-
PMH33 THE EFFECTIVENESS OF BUPRENORPHINE-MEDICATION ASSISTED TREATMENT AMONG AETNA'S OPIOID DEPENDENT MEMBERS: AN ANALYSIS OF HEALTH CARE COSTS AND SERVICE UTILIZATIONTkacz, J. / Un, H. / Leader, D. / Ruetsch, C. et al. | 2011
-
PMH52 PATIENT AND PHYSICIAN PREFERENCES AND SATISFACTION WITH ORAL AND LONG-ACTING INJECTABLE LONG-TERM ANTIPSYCHOTIC TREATMENT FOR PSHYCHOTIC DISORDERSPrû / tz, C. / Andersson-Ljungberg, G. / Hintikka, J. / Opjordsmoen, S. / Nielsen, J. / Hansson, F. et al. | 2011
-
PMH64 COMPARISON OF THE RISPERIDONE EQUIVALENT DOSES FOR THE 9 MOST FREQUENT TYPICAL AND ATYPICAL ANTIPSYCHOTICS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA BASED ON PRODUCT LABELS WITH ACTUAL DOSAGES PRESCRIBED IN A LARGE NATIONAL DATABASEParente, A. K. / Wang, R. H. / Jones, B. T. et al. | 2011
-
PMH70 WHAT DROVE THE DRAMATIC SLOWDOWN IN PSYCHIATRIC DRUG SPENDING GROWTH IN THE UNITED STATESMark, T. et al. | 2011
-
PMH80 UTILIZATION PATTERN AND TREATMENT ADHERENCE WITH MOOD STABILIZERS AND ATYPICAL ANTIPSYCHOTICS AMONG PEDIATRIC PATIENTS WITH BIPOLAR DISORDER: A RETROSPECTIVE CLAIMS-BASED STUDYMehta, S. / Patel, A. / Chen, H. et al. | 2011
-
PND7 PREVALENCE OF DRUG-TREATED MULTIPLE SCLEROSIS WITHIN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM: COMPARATIVE ANALYSIS WITH PUBLISHED PREVALENCE RATESTakemoto, M. L. / Takemoto, M. M. / Fernandes, R. A. / Duarte, G. G. / Tolentino, A. C. / Santos, P. M. / Moretti, A. I. et al. | 2011
-
PND17 IMPACT OF WALKING AND MOBILITY PROBLEMS ON REQUIREMENT FOR HEALTHCARE AMONG MULTIPLE SCLEROSIS PATIENTSRajagopalan, K. / Pike, J. / Jones, E. / Anderson, P. et al. | 2011
-
PND19 HUMANISTIC AND ECONOMIC BURDEN IN TUBEROUS SCLEROSIS COMPLEX WITH NEUROLOGICAL MANIFESTATIONS: SYSTEMATIC REVIEWHallett, L. / Foster, T. / Valentim, J. / Blieden, M. / Liu, Z. et al. | 2011
-
PND24 QUALITY OF LIFE USING TREATMENTS FOR PARKINSON'S DISEASE: AN ECONOMIC COMPARISON BETWEEN ROPINIROLE AND LEVODOPA/CARBIDOPAPatil, D. S. / Shah, A. J. / Sansgiry, S. et al. | 2011
-
PND42 THE ASSOCIATION BETWEEN PARKININSON'S DISEASE QUESTIONNAIRE (PDQ) SCORES WITH CARER STRAIN AND QUALITY OF LIFEJenkinson, C. / Peters, M. / Fitzpatrick, R. / Churchman, D. et al. | 2011
-
PND44 HEALTH-RELATED QUALITY OF LIFE IMPROVEMENTS WITH DYSPORT IN CERVICAL DYSTONIAColeman, C. / Chang, S. / Copley-Merriman, C. / Masaquel, C. / Hubble, J. et al. | 2011
-
CN4 PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING AMONG MEDICARE PATIENTS WITH CANCERCraver, C. / Gayle, J. / Balu, S. / Buchner, D. et al. | 2011
-
DM3 IMPACT OF MONTHLY PRESCRIPTION CAP ON MEDICATION PERSISTENCY AMONG PATIENTS WITH DIABETES, HYPERTENSION, OR HYPERLIPIDEMIAWang, C. C. / Wei, D. / Farley, J. et al. | 2011
-
DU3 IMPACT OF THE FDA'S ANTIPSYCHOTIC BLACK BOX WARNING ON PSYCHOTROPIC DRUG PRESCRIBING IN ELDERLY PATIENTS WITH DEMENTIA IN OUTPATIENT AND OFFICE-BASED SETTINGSDesai, V. C. / Heaton, P. C. / Kelton, C. et al. | 2011
-
EV1 DEVELOPMENT OF A GUIDANCE FOR INCLUDING PATIENT-REPORTED OUTCOMES (PROS) IN POST-APPROVAL CLINICAL TRIALS OF ONCOLOGY DRUGS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER)Basch, E. M. / Abernethy, A. / Mullins, C. D. / Tiglao, M. R. / Tunis, S. R. et al. | 2011
-
PHP5 INCENTIVE-BASED INTERVENTIONS – REWARDING PATIENTS FOR GOOD BEHAVIOURHaynes, S. / Costello, S. / Brooks-Rooney, C. / Hamer, N. et al. | 2011
-
PHP18 OPTIMAL HEALTH POLICY AND THE LINK BETWEEN OUTPUT MARKETS AND DEVELOPMENTPhilipson, T. et al. | 2011
-
PHP48 STATUS OF PHARMACIST AT COMMUNITY LEVEL: AN EXPLORATORY STUDY IN QUETTA, PAKISTANSaleem, F. / Al-Qazaz, H. K. / Azhar, S. / Ahmad, N. / Atif, M. / Haq, N. / Asif, M. / Iqbal, Q. et al. | 2011
-
PHP72 ASSESSING THE QUALITY OF PHARMACOECONOMIC STUDIES IN INDIA: A SYSTEMATIC REVIEWDesai, P. / Chandwani, H. / Rascati, K. et al. | 2011
-
Editorial Board| 2011
-
DS3 AVAILABILITY OF LABORATORY RESULTS DATA IN A CLAIMS DATABASE IN THE UNITED STATESHorne, L. N. / Ming, E. E. / Doyle, c. et al. | 2011
-
MC2 ASSESSING PREDICTORS OF MEDICATION ADHERENCE IN UNCONDITIONAL QUANTILE REGRESSION FRAMEWORKBorah, B. et al. | 2011
-
PHP1 USE OF STRUCTURAL EQUATION MODELING TO EXPLAIN CONSUMER BEHAVIOR TOWARDS GENERIC DRUG DISCOUNT PROGRAMSPatel, H. K. / Sansgiry, S. et al. | 2011
-
PHP51 MORTALITY AFTER SPOUSAL BEREAVEMENT IN BENEFICIARIES OF THE HEALTH PLANReis Neto, J. / Arantes, A. C. et al. | 2011
-
PHP68 THE 15 YEARS EXPERIENCE OF NEW DRUGS ADOPTION AND REIMBURSEMENT IN TAIWAN'S NATIONAL HEALTH INSURANCEHuang, W. F. / Hsieh, C. F. / Chen, G. T. et al. | 2011
-
PHP73 SYSTEMATIC LITERATURE REVIEW ON HETEROGENEITY OF RELATIVE EFFECTIVENESS AND RELATIVE EFFICACY OF MEDICINES IN EUROPEPuig-Peiró / R. / Towse, A. / Mestre-Ferrandiz, J. et al. | 2011
-
PHP100 PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADAKumar, J. / Bachman, E. M. et al. | 2011
-
PHP104 CURRENT USES OF AND PERCEPTIONS ABOUT FDAMA SECTION 114Lin, P. J. / Hughes, T. E. / Neumann, P. J. et al. | 2011
-
PCV10 THE EFFECT OF INTERACTIONS BETWEEN CLOPIDOGREL AND PROTON PUMP INHIBITORS ON ADVERSE CARDIOVASCULAR OUTCOMES IN COMMERCIALLY INSURED PATIENTS WITH ACUTE CORONARY SYNDROMEBhurke, S. / Martin, B. / Li, C. / Franks, A. / Bursac, Z. / Said, Q. et al. | 2011
-
PCV32 BUDGET IMPACT ANALYSIS OF INCREASING LMWH/FXI UTILIZATIONSchilling, B. / Powers, A. / Faria, C. / Choe, Y. / Broder, M. / Bentley, T. et al. | 2011
-
PSS5 WHAT INFLUENCES DENTAL CARE AMONG CHILDREN?Hufstader, M. / Vaidya, V. / White-Means, S. / Dishmon, B. / Sudharshan, L. / Sharma, G. et al. | 2011
-
PCV57 HEALTH CARE RESOURCE UTILIZATION AMONG T2DM PATIENTS WITH PRE-EXISTING MACROVASCULAR CONDITIONS: A MATCHED COHORT STUDYQiu, Y. / Fu, A. Z. et al. | 2011
-
PCV70 VARIATIONS IN THE IMPACT OF ILLNESS PERCEPTIONS AND MEDICATION BELIEFS ON MEDICATION COMPLIANCE OF ELDERLY VERSUS GERIATRIC HYPERTENSIVE COHORTS: A COMPARATIVE ANALYSISRajpura, J. R. / Nayak, R. et al. | 2011
-
PCV86 INSURANCE STATUS AND THE USE OF ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS) AND ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS AMONG POST-MYOCARDIAL INFARCTION (MI) PATIENTSKaisaeng, N. / Zhang, J. et al. | 2011
-
PSS3 PERSISTENCE WITH STATINS AND THE RISK OF AGE RELATED MACULAR DEGENERATION IN A LARGE HEALTH ORGANIZATION IN ISRAELChodick, G. / Shalev, V. / Goldstein, I. / Sror, M. et al. | 2011
-
PSS8 SYSTEMATIC REVIEW OF THE ECONOMIC LITERATURE ON ATOPIC DERMATITIS IN CHILDRENIskedjian, M. / Navarro, V. / Khondoker, F. / Farah, B. et al. | 2011
-
PSY24 COST-UTILITY ANALYSES OF DIFFERENT ERYTROPOIETINS IN ANEMIC PATIENTS ON DIALYSIS IN RUSSIAVorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. / Eliseeva, E. / Baev, V. / Vezikova, N. et al. | 2011
-
PSY41 HEALTH-RELATED QUALITY OF LIFE IN KAZAKHSTAN PATIENTS WITH HEREDITARY COAGULOPATHIESVorobyev, P. / Borisenko, O. / Zhulyov, Y. / Rybalova, T. / Krasnova, L. / Bezmelnitsyna, L. et al. | 2011
-
PSY69 MODELING THE IMPACT OF REFILL OR ADMINISTRATION GAPS ON PATIENT DRUG LEVELS OF THE TNF-ALPHA INHIBITORS ETANERCEPT AND INFLIXIMABIngham, M. / Carter, C. / Bolge, S. / Comisar, C. et al. | 2011
-
PSU22 A PATIENT-BASED QUESTIONANIRE TO ASSESS OUTCOMES OF FOOT SURGERY: VALIDATION IN THE CONTEXT OF SURGERY FOR HALLUX VALGUSDawson, J. / Jenkinson, C. / Churchman, D. et al. | 2011
-
PDB31 BENEFITS AND COSTS OF CONDUCTING SPONSORED CLINICAL TRIALS IN A PUBLICLY FUNDED NEW ZEALAND HOSPITAL: PRE-TRIAL, TRIAL AND FOLLOW-UPMurphy, L. / Maquire, W. et al. | 2011
-
PDB49 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TYPE-2 DIABETES: KOREAN AUDIT OF DIABETES-DEPENDENT QUALITY-OF-LIFEKim, D. M. / Kim, S. G. / Cho, D. H. / Kim, C. H. / Kim, C. S. / Lee, W. Y. / Won, G. J. / Ko, S. K. / Park, H. J. et al. | 2011
-
PDB70 BASELINE CHARACTERISTICS AND ANTIDIABETIC EXPOSURE IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH LIRAGLUTIDEMcAdam Marx, C. / Bouchard, J. / Aagren, M. / Conner, C. / Brixner, D. et al. | 2011
-
PIH1 HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF PATIENTS WITH CHRONIC CONDITIONS: EXCESS BURDEN OF COMORBID PHYSICAL AND MENTAL CHRONIC CONDITIONSBayliss, M. S. / Rendas-Baum, R. / White, M. K. / Maruish, M. E. / Bjorner, J. B. et al. | 2011
-
PIH6 THE DEFINITION AND PREVALENCE OF PSYCHOTROPIC POLYPHARMACY IN MEDICAID CHILDREN AND ADOLESCENTSPatel, A. R. / Chen, H. / Aparasu, R. R. / Sherer, J. T. et al. | 2011
-
PIH13 THE COST-EFFECTIVENESS OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING IN THE UNITED STATESGanz, M. / Shah, D. / Gidwani, R. / Filonenko, A. / Su, W. / Pocoski, J. / Law, A. et al. | 2011
-
PIH35 PHARMACISTS' ATTITUDE AND PREPAREDNESS REGARDING THE ISSUE OF ESCALATING PHARMACEUTICAL DEMAND DUE TO THE AGING BABY BOOMERSMakhija, D. / Sansgiry, S. / Johnson, M. L. / Essien, E. J. et al. | 2011
-
PIH38 EPIDEMIOLOGY OF ADOLESCENT AND YOUNG ADULT HOSPITAL UTILIZATION FOR ALCOHOL AND DRUG USE, SUICIDE, AND POISONING IN THE UNITED STATESBarnard, M. / Banahan, B. F. et al. | 2011
-
PIN7 EPIDEMIOLOGY OF HIV-RELATED NEUROPATHY – A SYSTEMATIC LITERATURE REVIEWGhosh, S. / Chandran, A. / Jansen, J. P. et al. | 2011
-
PMS6 THE PREVALENCE OF BONE FRACTURES IN OSTEOPOROSIS PATIENTS USING PROTON PUMP INHIBITORSChoi, I. S. / McGuire, M. / Park, H. K. / Suh, D. C. et al. | 2011
-
PMS25 COST-EFFECTIVENESS OF ABATACEPT OR INFLIXIMAB IN RHEUMATOID ARTHRITIS IN COLOMBIAAlfonso-Cristancho, R. / Aiello, E. C. / Roa, C. N. et al. | 2011
-
PMS40 HOW DOES OSTEOARTHRITIS SEVERITY INFLUENCE PATIENT PREFERENCES AND WILLINGNESS TO PAY FOR OSTEOARTHRITIS TREATMENTS?Hufstader, M. / White-Means, S. / Gourley, D. / Mele, N. / Yang, Y. / Hong, S. H. et al. | 2011
-
PMS54 ESTIMATING THE ECONOMIC BENEFITS OF POSITIVE SHIFTS IN FIBROMYALGIA SEVERITYCappelleri, J. C. / Bushmakin, A. G. / Zlateva, G. / Chandran, A. et al. | 2011
-
PRS28 EVALUATING THE IMPACT OF PHYSICIAN PROVIDED ASTHMA EDUCATION ON ABSENTEEISM IN CHILDREN: USING DATA FROM THE NATIONAL HEALTH INTERVIEW SURVEY (NHIS)Howe, J. L. / Potnis, P. / Vaidya, V. A. et al. | 2011
-
PRS33 EFFECTS OF EDUCATIONAL INTERVENTIONS FOR SELF-MANAGEMENT OF ASTHMA IN CHILDREN AND ADOLESCENTS: AN UPDATED SYSTEMATIC LITERATURE REVIEW AND META-ANALYSISNguyen, H. P. / Wong, S. / Schrauben, L. / Clark, N. M. / Grum, C. M. / Guevara, J. P. / Wolf, F. M. et al. | 2011
-
PRM4 WHAT IS IMPORTANT DURING THE PHARMACOECONOMIC EVALUATION OF CAM (COMPLEMENTARY AND ALTERNATIVE MEDICINE)?—A SURVEY RESEARCHZhang, F. / Li, S. C. / Fu, S. / Xie, J. / Zhang, Y. / Kong, L. et al. | 2011
-
PRM6 DEVELOPMENT OF AN INCREMENTAL COST-EFFECTIVENESS RATIO WITH SOME EQUITY IMPLICATIONWang, J. D. / Hung, M. C. et al. | 2011
-
PRM15 ADHERENCE IS ADHERENCE IS ADHERENCE: THE CONSISTENCY OF MORISKY ADHERENCE SCORES ACROSS THE COSTLIEST CHRONIC CONDITIONSDiBonaventura, M. D. / Annunziata, K. / Goren, A. / Gupta, S. et al. | 2011
-
PRM47 DEVELOPMENT OF LOCALLY ADAPTABLE VALUE ARGUMENTS: HOW CAN BUCKETING OF COUNTRIES AT GLOBAL LEVEL HELP MANUFACTURERS?Kirpekar, S. / Dummett, H. et al. | 2011
-
PRM48 DESIGN AND OPERATIONAL CONSIDERATIONS FOR PRAGMATIC CLINICAL TRIALS TO SUPPORT HEOR EVALUATIONSIshak, K. J. / Payne, K. A. / Schrammel, M. / Caro, J. J. et al. | 2011
-
PCN8 REAL LIFE OUTCOMES IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A PILOT STUDY IN FRANCE AND GERMANY ANALYSING BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB-BASED TREATMENTSBischoff, H. G. / Chouaid, C. / Vergnenegre, A. / Heigener, D. F. / Taylor-Stokes, G. / Roughley, A. / Walzer, S. et al. | 2011
-
PCN16 MAJOR CHANGES IN CHEMOTHERAPY REGIMENS ADMINISTERED TO BREAST CANCER PATIENTS DURING 2000-2008van Herk-Sukel, M. P. / van de Poll, L. / Creemers, G. J. / Lemmens, V. / van der Linden, P. / Herings, R. M. / Coebergh, J. W. / Voogd, A. et al. | 2011
-
PCN35 DOSING PATTERN AND COST COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA INPATIENTSLafeuille, M. H. / Bailey, R. A. / Senbetta, M. / McKenzie, R. S. / Lefebvre, P. et al. | 2011
-
PCN36 COST ANALYSIS, SAFETY, AND EFFICACY OF PEMETREXED/CISPLATIN COMPARED WITH BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NSCLC IN RUSSIADavey, P. / Rajan, N. / Kanivets, Y. / Barraclough, H. / Orlando, M. / Brnabic, A. J. / Han, B. et al. | 2011
-
PCN42 COSTS OF HOSPITAL EVENTS IN PATIENTS WITH METASTATIC COLORECTAL CANCEROverbeek, J. A. / Zhao, Z. / van Herk-Sukel, M. P. / Barber, B. L. / Gao, S. / Herings, R. M. et al. | 2011
-
PCN50 COST ANALYSIS OF DRG BASED FIRST LINE COLON CANCER THERAPIES IN HUNGARYValyi-Nagy, I. / Jozsa, G. et al. | 2011
-
PCN85 CANCER PATIENTS' PERCEPTION TOWARDS THE USE OF TRADITIONAL & COMPLEMENTARY MEDICINES (T&CM) FOR CANCER TREATMENT: A QUALITATIVE STUDYFarooqui, M. / Hassali, M. A. / Knight, A. / Shafie, A. A. / Tan, B. S. / Farooqui, M. A. et al. | 2011
-
PCN109 TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION OF METASTATIC PROSTATE CANCER PATIENTS BY PHYSICIAN SPECIALTYSenbetta, M. / Lafeuille, M. H. / Dean, J. / McKenzie, R. S. / Lefebvre, P. et al. | 2011
-
PCN136 ESTIMATING UTILITIES IN CANCER: A COMPARISON OF EQ-5D AND FACT-BASED ALGORITHMSPickard, A. S. / Ganguli, A. / Ray, S. / Cella, D. et al. | 2011
-
PCN138 A REVIEW OF EXPANDED ACCESS PROGRAMS (EAP) AND THEIR CONSIDERATION BY HEALTH PLAN DECISION-MAKERS IN THE UNITED STATESKhurdayan, V. / Rizzo, M. / Darity, A. / Mun, D. et al. | 2011
-
PGI1 INCIDENCE OF ANEMIA AND NEUTROPENIA FOLLOWING HCV TREATMENT INITIATION AND RELATED DRUG TREATMENT COSTS IN THE UNITED STATESDiels, J. / Gavart, S. / Nuyts, G. et al. | 2011
-
PGI5 COMPARISON OF HEALTH CARE UTILIZATIONS BETWEEN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE WHO SWITCHED FROM A BRANDED PROTON PUMP INHIBITOR TO A GENERIC PROTON PUMP INHIBITOR AND VICE VERSAXie, L. / Baser, E. / Wang, L. / Baser, O. et al. | 2011
-
PGI6 THE ECONOMIC BURDEN OF ADVANCED LIVER DISEASE AMONG PATIENTS WITH HEPATITIS C VIRUS: A STATE MEDICAID PERSPECTIVEMenzin, J. / White, L. A. / Nichols, C. / Deniz, B. et al. | 2011
-
PGI21 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS BEFORE AND AFTER 8 WEEKS' TREATMENT WITH MULTI-MATRIX MESALAMINE: COMPARISON WITH 2009 GENERAL POPULATION NORMS IN THE UNITED STATESYarlas, A. / Yen, L. / Hodgkins, P. et al. | 2011
-
PMH11 PERFORMANCE OF RISK ADJUSTMENT SCALES IN PREDICTING RISK OF HOSPITALIZATION AMONG DEMENTIA PATIENTS: A MEPS STUDYBhowmik, D. / Mehta, S. / Chitnis, A. / Dwibedi, N. / Kamble, P. / Johnson, M. L. et al. | 2011
-
PMH34 MEASURING THE IMPACT OF PERSISTENCE WITH PSYCHOTROPIC DRUG THERAPY ON TREATMENT COSTS FOR PATIENTS WITH SCHIZOPHRENIAZolfaghari, S. / McCombs, J. et al. | 2011
-
PMH74 UTILIZATION, PRICE AND SPENDING TRENDS FOR SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS IN THE UNITED STATES MEDICAID PROGRAM: 1991-2009Isla, A. / Guo, J. J. / Lin, A. C. / Kelton, C. M. / Heaton, P. C. et al. | 2011
-
PMH83 ESTIMATING SAMPLE SIZE FOR PSYCHOMETRIC STUDIES USING CONFIRMATORY FACTOR ANALYSISCole, J. C. / Cheng, R. et al. | 2011
-
PMH84 PERFORMANCE OF TWO INSTRUMENTAL VARIABLES TO EXAMINE THE RISK OF DEATH IN DUAL ELIGIBLE ELDERLY NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTSAparasu, R. R. / Mehta, S. / Chen, H. et al. | 2011
-
PND37 INVESTIGATION OF THE PSYCHOMETRIC PROPERTIES OF THE SHORT PARKINSON'S EVALUATION SCALE/SCALES FOR OUTCOMES IN PARKINSON'S DISEASE (SPES/SCOPA)Buck, P. O. / Conner, J. B. / Castelli-Haley, J. / Wilson, R. E. / Seeberger, L. C. et al. | 2011
-
PND46 THE IMPACT OF EPILEPSY ON ADULT AND PAEDIATRIC PATIENT'S LIVES: A CONCEPTUAL MODELKerr, C. / Nixon, A. / Angalakuditi, M. et al. | 2011
-
PCV1 DOES ROUTE OF ADMINISTRATION FOR ESTROGEN HORMONE THERAPY IMPACT RISK OF VENOUS THROMBOEMBOLISM: ESTRADIOL TRANSDERMAL SYSTEM VERSUS ORAL ESTROGEN-ONLY HORMONE THERAPYLaliberté / F. / Dea, K. / Duh, M. S. / Kahler, K. H. / Rolli, M. / Lefebvre, P. et al. | 2011
-
PCV22 META REGRESSION ANALYSIS TO INDIRECTLY COMPARE THE SAFETY AND EFFICACY OF DALTEPARIN TO ENOXAPARIN IN PATIENTS WITH UNSTABLE CORONARY ARTERY DISEASEDranitsaris, G. / Jelincic, V. / Choe, Y. et al. | 2011
-
PCV25 MANAGEMENT OF ACUTE ISCHEMIC STROKE AND ITS LONG TERM EVOLUTION IN THE UNITED STATES AND CANADARouleau, A. / Gobaux, V. / Guilhaume, C. / Yiou, A. / Milea, D. et al. | 2011
-
PCV33 USE OF SECONDARY DATA SOURCES TO ESTIMATE INPATIENT COSTS AND PAYMENTS FOR ACUTE CORONARY SYNDROMEOhsfeldt, R. / Bhandary, D. / Fox, K. M. / Gandhi, S. K. et al. | 2011
-
PCV44 CHANGING COST-EFFECTIVENESS EARLY IN THE PRODUCT LIFE CYCLE: THE EXAMPLE OF CLOPIDOGREL BISULFATEvan der Goes, D. N. / Willke, R. J. / Garrison, L. et al. | 2011
-
PCV50 COST-EFFECTIVENESS ANALYSIS COMPARING DABIGATRAN AND ADJUSTED-DOSE WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATIONZhao, Y. / Lim, L. / Coleman, C. I. et al. | 2011
-
PCV51 THE VALUE OF ATORVASTATIN OVER THE PRODUCT LIFE CYCLEGrabner, M. / Johnson, W. R. / Abdulhalim, A. M. / Kuznik, A. / Mullins, C. D. et al. | 2011
-
PCV55 COST-MINIMIZATION ANALYSIS OF THROMBOPROPHYLAXIS FOLLOWING ELECTIVE TOTAL HIP ARTHROPLASTYDelate, T. / Clark, N. / Cho, S. / Witt, D. et al. | 2011
-
PCV72 THE RISK OF STROKE AND PREVENTATIVE STEPS AMONG PATIENTS DIAGNOSED WITH ATRIAL FIBRILLATION IN THE UNITED STATESGupta, S. / Wagner, J. S. / Goren, A. / DiBonaventura, M. et al. | 2011
-
PCV80 MEDICATION THERAPY MANAGEMENT IMPROVES HEALTH CARE UTILIZATION AND COSTS FOR EMPLOYERSPinto, S. L. / Partha, G. / Jania, A. et al. | 2011
-
PCV98 USE OF ELECTRONIC MEDICAL RECORDS TO ASSESS THE CLINICAL AND ECONOMIC IMPACT OF NON-MEDICAL SWITCHING BETWEEN DIFFERENT ANGIOTENSIN RECEPTOR BLOCKERS (ARBS)Kamal, K. M. / Zacker, C. / Civitarese, L. et al. | 2011
-
PCV103 PHARMACIST INTERVENTIONS WITHIN A COMMUNITY PHYSICIAN BASED MEDICAL HOME PRACTICE: DIABETES CLINICAL OUTCOMESWilley, V. J. / Reinhold, J. A. / Kozuch, J. M. / Amin, S. M. / Kelly, B. L. / Kim, E. A. / Willey, K. H. et al. | 2011
-
PSY50 PRESCRIPTION MONITORING PROGRAMS' UTILIZATIONFleming, M. L. / Barner, J. C. / Chandwani, H. / Okoro, T. / Weber, S. et al. | 2011
-
PSS14 COST-UTILITY ANALYSIS OF RANIBIZUMAB (LUCENTIS®) IN WET-AMD BASED ON REAL-LIFE DATA COLLECTED IN THE HELIOS STUDY AFTER RANIBIZUMAB REIMBURSEMENT IN BELGIUMMoeremans, K. / Gerlier, L. / Drieskens, S. / Annemans, L. / Brié / H. / Deruyck, M. / Faes, P. / Vancayzeele, S. et al. | 2011
-
PSS19 PSYCHOMETRIC EVALUATION OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE 25 AND VISUAL FUNCTION QUESTIONNAIRE UTILITY INDEX IN PATIENTS WITH NON-INFECTIOUS INTERMEDIATE AND POSTERIOR UVEITISNaik, R. K. / Gries, K. S. / Rentz, A. / Kowalski, J. W. / Revicki, D. A. et al. | 2011
-
PMD3 PARTIAL RESPONDERS IN SCHIZOPHRENIAMillier, A. / Azorin, J. M. / Angermeyer, M. C. / Toumi, M. et al. | 2011
-
PSY2 THE ASSOCIATION BETWEEN THERAPY WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND HEMOGLOBIN LEVELChodick, G. / Raz, R. / Leshem, E. / Steinvil, A. / Berliner, S. / Zeltser, D. / Rogowski, O. / Shalev, V. et al. | 2011
-
PSY37 THE PAIN MANAGEMENT IS ALWAYS A PUBLIC HEALTH CHALLENGEBertin, P. / Rahhali, N. / Auges, M. / Taieb, C. et al. | 2011
-
PSY52 POTENTIAL DRUG-DRUG INTERACTIONS (DDIS) WITH PAIN MEDICATIONS AMONG PATIENTS WITH BACK AND NECK PAIN DIAGNOSES CATEGORIZED INTO NOCICEPTIVE, NEUROPATHIC OR MIXED PAIN COHORTSKozma, C. / Benson, C. / Patel, A. / Provenzano, D. / Slaton, T. / Biondi, D. / Kim, M. et al. | 2011
-
PSY56 CONTROLLED SUBSTANCE PRESCRIBING AND UTILIZATION OF PRESCRIPTION DRUG MONITORING PROGRAMSTalbert, J. / Perin, N. / Blumenschein, K. / Freeman, P. R. et al. | 2011
-
PSY55 NATIONAL TRENDS IN ANTI-OBESITY MEDICATION USE FROM 2002 TO 2007Mehta, H. B. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. L. et al. | 2011
-
PSY67 REASONS FOR INITIATING INTRAVENOUS BIOLOGIC THERAPY AMONG PATIENTS WITH IMMUNOLOGY CONDITIONS: SUBSET ANALYSIS OF PRIOR SUBCUTANEOUS INJECTION (SQ) USERS AND IMPLICATIONS FOR SHARED DECISION MAKINGBolge, S. / Vanderpoel, J. / Eldridge, H. / Mody, S. / Lofland, J. / Ingham, M. et al. | 2011
-
PUK6 LOW-MOLECULAR-WEIGHT HEPARIN IN CHRONIC HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSISBurke, N. / Tarride, J. E. / Bowen, J. / von Keyserlingk, C. / Lim, W. / Crowther, M. / Goeree, R. et al. | 2011
-
PUK13 COST-EFFECTIVENESS ANALYSIS OF THE EARLY CONVERSION OF TACROLIMUS TO MTOR INHIBITORS IN PATIENTS WITH RENAL TRANSPLANTATIONGamboa, O. / Montero, C. / Mesa, L. / Benavides, C. / Reino, A. / Castillo, J. S. et al. | 2011
-
PUK20 EARLY DETECTION, SCREENING, AND MANAGEMENT OF CHRONIC KIDNEY DISEASE AMONG ACTIVELY EMPLOYED – AN INTEGRATED POPULATION HEALTH MANAGEMENT APPROACHHarshman, R. / Naim, A. / Carter, J. / Richerson, G. / Nair, K. V. et al. | 2011
-
PMD7 DIFFERENCES IN OUTCOMES MEASURES OF DIABETES PATIENTS USING AN INSULIN DEVICE AND A CONVENTIONAL HUMAN INSULIN VIAL/SYRINGEBaser, O. / Wang, L. / Yuce, H. / Xie, L. / Dysinger, A. H. et al. | 2011
-
PMD29 PATIENT TIME AND INDIRECT COSTS ASSOCIATED WITH SENSOR-AUGMENTED INSULIN PUMP THERAPY IN TYPE 1 DIABETESKamble, S. / Weinfurt, K. P. / Perry, B. M. / Schulman, K. A. / Reed, S. D. et al. | 2011
-
PDB33 EVALUATING THE COST-EFFECTIVENESS OF SWITCHING FROM INSULIN GLARGINE TO INSULIN DETEMIR IN PATIENTS WITH TYPE-2 DIABETES IN A CHINESE SETTING: A MODELING STUDY BASED ON THE PREDICTIVE STUDYYang, L. / Lay, A. L. / Chang, J. H. et al. | 2011
-
PDB36 AN ECONOMIC MODEL OF THE EFFECTS OF QUICK RELEASE BROMOCRIPTINE MESYLATE VERSUS ALTERNATIVE ORAL ANTIDIABETIC DRUGS ON HOSPITALIZATIONS AND COSTSMenzin, J. / Duczakowski, C. / Friedman, M. / Neumann, P. / Scranton, R. et al. | 2011
-
PDB40 EXAMINING ADHERENCE WITH MEDICATIONS USED IN TREATING DIABETIC PERIPHERAL NEUROPATHIC PAIN AND THEIR ASSOCIATION WITH ORAL ANTIDIABETIC MEDICATION ADHERENCEOladapo, A. O. / Barner, J. C. / Rascati, K. L. / Strassels, S. et al. | 2011
-
PDB47 NATIONAL IMPACT OF HEALTH CARE ACCESS ON HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH DIABETES IN THE UNITED STATESTundia, N. / Desai, V. C. / Berry, E. / Heaton, P. C. et al. | 2011